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Abstract
Two North American ginseng extracts were used to test sexual behavior in healthy rats
and pre-diabetic rats, with erectile dysfunction, after four weeks of oral administration.
Behavioral tests assessed sexual performance while animal tissues were used to examine
eNOS and nNOS protein and mRNA in central and peripheral sites known to control
erectile function. Results show an improvement in erectile function during copulation in
healthy rats with chronic treatment of ethanol extract of NA ginseng but not aqueous
extract. In addition, eNOS and nNOS mRNA was increased in penile tissue and nNOS
staining was increased in the paraventricular nucleus of the hypothalamus with acute
treatment of ethanol extract. For pre-diabetic rats, ethanol extract improved erectile
function during mating and penile reflex tests. Also, nNOS was increased in penile tissue
with chronic treatment and eNOS with acute treatment. The results show NA ginseng
ethanol extract can improve erectile function.
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Chapter 1:

1.1 Introduction

1.1.1. Male Rat Sexual Behavior

Complex interactions of hormonal and neurochemical signals regulate the various
aspects of male sexual behavior (Pfaus et al., 2001). Rats exhibit discontinuous sexual
mating in comparison to the “locked” behavior of humans where physical contact and
penetration are maintained until ejaculation (Pfaus, 2009). In summary, olfactory, tactile,
and auditory cues from a receptive female stimulate desire and elicit a consummatory
response from the male rats. The male will mount the female from the rear and perform
several rapid pelvic thrusts; if no vaginal penetration occurs then the action is called a
mount (Pfaus, 2009). If during a mount the male detects the female vagina and obtains an
erection rigid enough for penetration, he will give one strong thrust and insert his penis;
this is known as an intromission (Pfaus, 2009). After either a mount or an intromission
the female darts away while the male dismounts and typically grooms his genitals; this
gives rise to the discontinuous mating.

After a few seconds, the female will again display preceptive behavior to
stimulate desire in the male (Beach, 1976). The male will continue to mount and intromit
the female until ejaculation is reached when the male performs rhythmic thrusts and
inserts a seminal plug into the vagina followed by a slow dismount (Pfaus, 2009). After

ejaculation, a post-ejaculatory interval (PEI) occurs for a few minutes where the male
will not engage in sexual behavior; the PEI ends once the male successfully intromits the
female (Clark, 1995).

The male will initiate another copulatory series if presented with a receptive
female and will typically repeat five to ten copulatory series until satiation (Clark, 1995).
Importantly, previous sexual experience facilitates the initiation and overall performance
of male sexual behavior, as evidenced by decreased latencies to initiate sexual behavior
and increased sexual performance (Balfour et al., 2004; Pitchers et al., 2010). Successful
male sexual behavior is dependent on intact erectile function to maintain a penis rigid
enough for vaginal penetration.

1.1.2. Experiments on Erectile Function

Many behavioral tests have been developed to determine the quality and quantity
of erections in rats. During copulation, measurements for erectile function are evaluated
based on mount and intromission frequency and copulation efficiency (CE) (Clark,
1995). CE is a ratio of the number of total successful intromissions to the number of total
mounts and intromissions (Clark, 1995). In essence, CE is a measure of penile rigidity; it
compares the amount of successful vaginal penetrations to the total number of attempted
vaginal penetrations.

Simulated tests for erectile function have been developed to evaluate erections
outside of copulation. Noncontact erections (NCE), also known as psychogenic erections
in humans, are erectile responses initiated by sexual arousal (Sachs et al., 1994). In
rodents, stimulation from receptive females in the form of olfactory, auditory, and tactile
vibrations elicits erectile responses in male rats even without physical contact (Sachs et
al., 1994). The male displays hallmark signs of erections based on rhythmic hip
contractions and flexions while grooming his genitals (Sachs, 1996). The number or
erections and timing to the first erection are measures of erectile function induced by
arousal.

An additional method of examining erectile function is a reflexive test known as
ex copula. During the test, rats are restrained in a supine position, the prepuce is retracted
and light pressure is used to hold the penis in place and maintain prepuce retraction. Both
tactile stimulation and prepuce retraction elicit erectile reflexes of varying magnitudes
that can be analyzed for erectile function (Sachs and Garinello, 1978). In summary, three
levels of erections occur. El erections occur when the base of the glans swells with
blood, E2 erections occur when the tip of the glans swell with blood, and E3 erections
occur when the tip of the glans swell so the circumference of the tip is greater than the
base (Sachs and Garinello, 1978). Intracavemous pressure increases as the erectile reflex
increases in number, indicating an increase in penile rigidity (Bemabe et al., 1995). In
addition, penile flexions and clusters of erectile responses, which occur during ex copula
tests can also be used to help measure erectile reflexes (Sachs and Garinello, 1978).
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1.1.3. Central Regulation of Penile Erection

Penile erections involve tumescence of the cavernous bodies by engorging them
with blood when penile veno-occlusion occurs in conjunction with dilation of penile
arteries (Giuliano and Rampin, 2004; Hidalgo-Tamola and Chitaley, 2009). Control of
erection involves a complex interaction between sensory inputs and neural and peripheral
systems (Argiolas and Melis, 2005). In humans, tactile, visual, and imaginative stimuli
can initiate an erection, whereas in rodents, auditory and olfactory cues can also
contribute to inducing erectile responses (Sachs, 2000; Steers, 2000). Although the neural
control for erections originate in the spine, erections are under excitatory influences from
supraspinal sites (Rosen and Sachs, 2000) such as the paraventricular nucleus of the
hypothalamus (PVN; Figure 1).

Paraventricular Nucleus of the Hypothalamus: The PVN receives projections
from the areas of the brain involved in male sexual behavior and sends oxytocin
projections to extra-hypothalamic brain regions (Argiolas and Melis, 2005)
(Figure 1.1). Importantly for modulating erections, the PVN is thought to be the
only supraspinal brain region to send projections to the spinal cord to regulate
erectile function (Argiolas and Melis, 2005). Stimulation of the PVN induces
penile erections in animals (Melis et al., 1994; Chen and Chang, 2002, 2003).
Lesions of the PVN have region-specific effects; lesions that incorporate both
parvo- and magnocellular subregions of the PVN using radiofrequency show
impairment on male copulation as indicated by increased mounts and ejaculatory

latency and a decreased number of NCE (Liu et al., 1997). However, lesions in
the PVN using N-methyl-D-aspartic acid, which only destroys the parvocellular
subregion, showed no impairment in copulatory performance but decreased the
number of NCE (Ackerman et al., 1997; Liu et al., 1997). Activation of the
oxytocin neurons in the PVN requires an intracellular increase in nitric oxide
(NO) production through the activation of neuronal nitric oxide synthase (nNOS);
however, the mechanism through which NO activates oxytocin neurons is
currently unknown (Melis et al., 1998; Chen and Chang, 2002; Argiolas and
Melis, 2005). In conclusion, the PVN plays a supportive, non-essential role in
erectile function and is thought to be the only supraspinal region with connections
to the spinal cord that contributes to the regulation of erections.

1.1.4. Peripheral Control of Penile Erection

Upon appropriate appetitive stimulation, projections from the central nervous
system increase the parasympathetic tone and decrease the sympathetic output of nerves
in the penis (Andersson, 2001). Specifically, parasympathetic stimulation activates
nonadrenergic-noncholenergic (NANC) nerves, which increases nNOS activity that
further increases NO release into the vasculature. NO is vital for tumescence in erectile
tissue (Rajfer, 2008). NO then enters the smooth muscle cells to activate soluble
guanylate cyclase (sGC) and increase its production of cyclic guanosine monophosphate
(cGMP) (Giuliano and Rampin, 2004). cGMP then causes a cascade of events leading to
the hyperpolarization and relaxation of the smooth muscle cells and, consequently, the
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Modified from (Melis and Argiolas, 2010)

Figure 1.1. Schematic diagram of the paraventricular nucleus of the hypothalamus with
oxytocinergic projections. Oxytocinergic projections to the spinal cord are thought to be
the only projections to the spinal cord that regulate erectile function.

engorgement of cavernous bodies to form an erection (Rajfer et al., 1992). cGMP can be
inactivated to 5’-cGMP by phosphodiesterase type 5 (PDE5) in the penile tissue
(Rybalkin et al., 2003). Consequently, PDE5 has become a pharmacological target for
men with erectile dysfunction (ED).

Shear pressure in the endothelial cells of the penile vasculature increase NO
production from endothelial nitric oxide synthase (eNOS), which also contributes to the
activation of sGC in smooth muscle cells (Hidalgo-Tamola and Chitaley, 2009).
Production of NO via nNOS is seen as the initiator of erections while eNOS is viewed as
the maintainer of erections since an increase in intracavemous pressure is required before
eNOS increases its NO production (Gratzke et al., 2010).

Proper erectile function can deviate from healthy conditions at many areas in the
central and peripheral erectile pathways. Moreover, ED can occur through psychological
and cardiovascular pathological states; however, there is no consensus on the mechanism
of ED development (Rosen et al., 2004). Furthermore, it is likely that a combination of
alterations contribute to the development of ED in both healthy and diabetic patients.

1.2.1. Erectile Dysfunction

The prevalence of ED varies based on the population analyzed, the methods of
assessing ED, and the threshold used to classify a patient with ED (Prins et al., 2002).
Regional variation with identical screening methods of men between the age of 20 to 75

shows a range of ED prevalence between 10 to 22% (Rosen et al., 2004). Overall,
approximately 16% of men experience ED; prevalence of ED increases with age, high
blood pressure (26%), cholesterolemia (26%), depression or anxiety (26%), and diabetes
(39%). O f this population, 58% seek treatment and only 16% who are prescribed PDE5
inhibitors, such as Sildenafil (Viagra), actively use the drug (Rosen et al., 2004). In
addition, not all men respond positively to PDE5 inhibitors. Only 56% of men with Type
2 diabetes mellitus (T2DM) respond to treatment as compared to 86% of the general
population (Rendell et al., 1999). Also, after a year of PDE5 treatment, men who
responded positively to PDE5 inhibitors may revert back to pre-treatment conditions
(Penson et al., 2003).

1.2.2. Erectile Dysfunction in Type 2 Diabetes Mellitus

Development of ED can occur when the NO/cGMP pathway in penile tissue is
disrupted. Diabetes can negatively affect multiple mechanisms through which normal
erectile function occurs: impaired vasodilatory signalling through NANC dysfunction
and/or endothelial damage, oxidative stress, hypogonadism, and veno-occlusive
dysfunction, to name a few (Hidalgo-Tamola and Chitaley, 2009).

Although NANC dysfunction is established in Type 1 diabetes mellitus (T1DM),
the role of NANC dysfunction in T2DM is still unclear due to conflicting results from
different studies. In mice, no significance was reported between control and T2DM mice
in regards to NANC dysfunction; however, Otsuka Long Evans Tokushima Fatty
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(OLETF) rats, as a model of T2DM, presented with decreased nNOS immunofluorescent
staining in penile nerves and a 40% reduction in nNOS protein expression (Vemet et al.,
1995; Hidalgo-Tamola and Chitaley, 2009). In addition to NANC dysfunction, loss of
endothelial NO production may contribute to the pathological state of impaired penile
vasodilation. Decreased immunofluorescent staining and protein expression of eNOS was
found in OLETF rats (Jesmin et al., 2003). Given the discrepancy in NANC dysfunction
and the limited studies on T2DM endothelial function, further experiments are needed to
verify any decrease in NO production in T2DM models.

In diabetes, the chronic state of hyperglycemia causes inflammation and an
increase in the formation of reactive oxygen species (ROS), such as superoxide anions
(Gur et al., 2009). Superoxide anion reacts with NO to form peroxynitrite, which is
another ROS. Peroxynitrite is pro-apoptotic and causes vascular damage to small penile
resistance arteries causing endothelial apoptosis, which decreases the contribution of NO
from eNOS (Jeremy et al., 2007). ROS also contribute to ED by scavenging the
vasculature for NO, causing a direct decrease in its bioavailability to cause vasodilation
(Hidalgo-Tamola and Chitaley, 2009). In addition, the antioxidant glutathione, which
reduces ROS, is decreased in hyperglycaemic conditions (Gur et al., 2009). As such,
diabetic populations experience an increase in oxidative stress as well as a decrease in
antioxidant levels to combat oxidative stress.

Men with both ED and T2DM have a higher prevalence of hypogonadism;
approximately 25% of men with both pathologies experience hypogonadism compared to

less than 13% in men with ED who are not diabetic (Corona et al., 2004; Corona et al.,
2006). Adipose tissue converts androgens to estrogens via aromatase, which causes an
overall decrease in testosterone levels (Hidalgo-Tamola and Chitaley, 2009).
Testosterone has an important role in regulating both erectile function and male sexual
libido; severely decreased testosterone levels can lead to a reduction in both parameters
(Mills and Lewis, 1999; Gray et al., 2005).

Finally, T2DM rats inadequately maintain intracaveronsal pressure after saline
infusion indicating veno-occlusive dysfunction in penile tissue (Kovanecz et al., 2006).
Indeed, studies have shown that 39-67% of patients with T2DM experience venoocclusive dysfunction (Colakoglu et al., 1999; Metro and Broderick, 1999). In
conclusion, treatment of diabetic patients with ED may require combination therapies
since PDE5 inhibitors alone may not provide adequate pro-erectile treatment and the
combined secondary effects of diabetes decreases erectile capacity.

1.2,3. The Obese Zucker Rat: A Model of Pre-Diabetes

Even though 90% of DM patients are categorized with T2DM, previous studies
focus on T1DM animals models (Hidalgo-Tamola and Chitaley, 2009). The Obese
Zucker (OZ) rat is a model for pre-diabetes with similar pathologies as T2DM. OZ rats
have an autosomal recessive mutation in the leptin gene and are glucose intolerant
(Kasiske et al., 1992). Also, similar to T2DM patients, OZ rats have hyperinsulinemia,
insulin resistance, hyperlipidemia, obesity, hypertension, and impaired vasodilation

(Kasiske et al., 1992). These secondary pathologies of pre-diabetes contribute to ED
development in OZ rats (Edmonds and Withyachumnamkul, 1980; Edmonds et al., 1982;
Withyachumnamkul and Edmonds, 1982; Doherty et al., 1985; Hemmes and Schoch,
1988).

Male OZ rats have a decrease in intromission latency (Withyachumnamkul and
Edmonds, 1982), intromission frequency (Doherty et al., 1985), and ejaculation latency
(Doherty et al., 1985). The OZ rat is a good model for testing pharmacological therapies
for ED because diabetes is not fully established and the secondary effects of diabetes on
erectile function are not completely manifested to potentially cause irreversible ED.
However, it is not uncommon for the sexual performance of older OZ rats to be so
severely impaired that they do not copulate (Young et al., 1986).

1.3.1. Ginseng Plant

The ginseng genus is composed of a minimum of nine species including Panax
ginseng (Asian ginseng) and Panax quinquefolius (North American (NA) ginseng)
(Leung and Wong, 2010). Ginseng plants are perennial herbs that have been used for
millennia as health tonics either alone or in combination with other medicinal ingredients
(Attele et al., 1999) (Figure 1.2). Ginsenosides are considered the main, active, medical
constituent in the ginseng genus and were first isolated in 1963 (Shibata et al., 1963).
Ginsenosides are triterpene saponins with a dammarane skeleton consisting of multiple
sugar moieties; they possess a rigid four trans-ring steroid skeleton
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Modified from: http://www.wildcrafting.net/forage/plant/129/

Figure 1.2. Photograph of Panax quinquefolius
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(Shibata et al., 1965; Leung and Wong, 2010). In NA ginseng, ginsenosides Rbl, Re, Rd,
Re, Rgl, and Rb3 constitute more than 70% of the total ginsenoside content and provide
a basis to standardize NA ginseng extracts (Lim et al., 2005; Wang et al., 2005).
Ginsenoside Rf is found exclusively in Asian ginseng and can be used as a marker to
distinguish Asian from NA ginseng (Li et al., 2000). Importantly, differing effects on
angiogenesis and immunomodulation have been reported based on the solvent used to
create the ginseng extract (Azike et al., 2011).

As a general health tonic, ginseng has traditionally been used to treat multiple
pathological states. It is rationalized that the ginseng plant can be used as a health tonic
since it contains more than 20 ginsenosides and each ginsenoside may cause differing
effects on certain receptors or tissues (Attele et al., 1999). However, the ginsenoside
content in ginseng root extracts varies by species, age, cultivation practise, time of
harvest, and manufacturing methods (Lim et al., 2005; Schlag and McIntosh, 2006).
Thus, developing crops with consistent ginsenoside contents is difficult. In response,
creating a composite extract from multiple farming locations can help minimize
variability of ginsenosides. In addition, recent studies are indicating polysaccharides in
the ginseng root may contribute to some of the medicinal qualities of ginseng (Wang et
al., 2010a).
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1.3.2. Ginseng Treatment for Enhancing/Rescuing Erectile Function

Among its many uses as a health tonic and “adaptogen”, ginseng has been used
for millennia as a natural aphrodisiac in men. Recently, the scientific literature has begun
to support this claim. Various animal models have been used to examine the effects of
ginseng extracts on male sexual performance. Tests on Asian and Korean Red ginseng
(the steamed form of Asian ginseng) have used humans (Hong et al., 2002; de Andrade et
al., 2007; Jang et al., 2008; Kim et al., 2009), rats (Kim et al., 1976), mice (Yoshimura et
al., 1998), and rabbits (Choi et al., 1999). In addition, one study examined the effects of
ginsenoside Rgl on copulatory behavior in mice (Wang et al., 2010b) and another study
used NA ginseng on rats (Murphy et al., 1998).

Studies on sexual performance in humans using Asian ginseng show an increase
in erectile function as indicated by a self reporting questionnaire called the International
Index of Erectile Function (IIEF). Tests indicate that ginseng treatment was able to
improve scores on penetration, erection maintenance, and rigidity in men with ED after
12 weeks of treatment (de Andrade et al., 2007). In addition, after 8 weeks of treatment
penile rigidity in men with ED was increased upon auditory and visual stimulation, as
indicated by the RigiScan test (Hong et al., 2002). However, a systemic review indicates
that although chronic ginseng treatment shows promise for treating ED in humans, more
studies are required to draw definitive conclusions (Jang et al., 2008).
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Animal studies indicate ginseng can be used to increase erectile function (Choi et
al., 1999) as well as increase male sexual performance during mating (Kim et al., 1976;
Murphy et al., 1998; Yoshimura et al., 1998; Wang et al., 2010b). In summary,
electrostimulation of pelvic nerves in rabbits treated for three months with Korean Red
ginseng caused an increase in intracavemous pressure, indicating increased penile rigidity
(Choi et al., 1999). This occurred with an increase in relaxation of penile muscles to
acetylcholine in ginseng-treated rabbits compared to control animals (Choi et al., 1999).
Regarding sexual performance, ginseng treatment was able to enhance mating behavior in
mice and rats with (Yoshimura et al., 1998) and without (Kim et al., 1976) impaired
performance, respectively. Furthermore, sexual arousal was enhanced with NA ginseng
treatment in healthy rats as indicated by decreased latencies to mount, intromit, and
ejaculate (Murphy et al., 1998). The increase in sexual arousal occurred after 14 days of
ginseng treatment and persisted until 28 days of treatment alongside reductions in
circulating prolactin levels (Murphy et al., 1998). The authors conclude that increased
dopaminergic activity in the central nervous system caused a decrease in prolactin levels,
which they correlate to increased male rat copulatory behavior (Murphy et al., 1998).
However, this may not translate to humans since Korean Red ginseng treatment has not
been shown to influence prolactin levels (de Andrade et al., 2007).

Finally, ginsenoside Rgl increased male mice copulatory behavior after 20 days
of treatment (Wang et al., 2010b). In addition, Rgl increased plasma testosterone as well
as cGMP and NO levels in penile tissue (Wang et al., 2010b). However, testosterone
levels were reported to be unchanged with NA ginseng treatment in rats (Murphy et al.,
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1998) and with Korean Red ginseng treatment in humans (de Andrade et al., 2007). As
such, further tests are required to clarify hormone changes in plasma with ginseng
treatment regarding male sexual behavior.

With regards to penile erectile function, experiments in vitro (Chen and Lee,
1995; Rimar et ai., 1996) and in vivo (Lee et al., 1981) show the vasodilatory effect of
ginseng on the vasculature. In particular, Asian ginseng extract applied to rabbit corpus
cavemosum caused a dose-dependent vasodilatory effect, which was enhanced with
superoxide dismutase and abolished by a NOS inhibitor (Chen and Lee, 1995). These
results indicate a role of NO in the vasodilatory effects of ginseng in the penile
vasculature.

In addition, as previously stated, the maintenance of healthy endothelial cells in
the vasculature is imperative to proper erectile function. Ginseng has been shown to
possess antioxidant properties (Kim et al., 1992; Gillis, 1997) that would protect
endothelial cells from oxidative stress in pathological conditions such as diabetes
(Hidalgo-Tamola and Chitaley, 2009). Moreover, the use of ginseng may provide diabetic
patients with the needed boost in antioxidant levels to protect the endothelial cells from
ROS and provide pro-erectile effects by activating the NO/cGMP pathway.
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1.4. Objectives and Hypothesis

The overall goal of this study is to determine the effects of NA ginseng extracts
on sexual performance and erectile function in healthy (chapter 2) and pre-diabetic
(chapter 3) male rats. While ginseng has shown promise in enhancing male sexual
function, further studies are needed to validate this claim. In addition, only one study has
been published examining the effects of NA ginseng on male sexual performance by
analyzing measures for sexual arousal. The study by Murphy and colleagues did not
measure effects of NA ginseng on erectile function. As such, further studies are needed to
determine potential effects of NA ginseng at enhancing erectile function in healthy
models and potential effects of NA ginseng at improving sexual behavior in ED. The
mechanisms by which ginseng acts to elicit pro-erectile effects remains largely
unexplored, although evidence thus far indicates increased activity in the NO/cGMP
pathway and increased ROS scavenging (Kim et al., 1992; Chen and Lee, 1995; Gillis,
1997). We hypothesize that NA ginseng will increase sexual performance in healthy rats
and partially recover erectile function in pre-diabetic rats by acting on the NO/cGMP
pathway. In addition, we will investigate expression of NOS in pro-erectile brain areas in
healthy rats. Indeed, ginseng has been shown to act centrally to produce effects such as
memory enhancement (Nah et al., 2007; Radad et al., 2010). Another objective of this
study is to examine two common ginseng extract preparations, ethanol and aqueous, to
help determine preparation differences and help hypothesize on the active constituents in
NA ginseng that enhance male sexual performance.

Finally, effects of NA ginseng administration on anxiety-like behaviors will be
conducted to determine if effects on sexual behavior are occurring secondary to negative
effects on this parameter. Currently, chronic administration of Asian ginseng is not
known to influence anxiety-like behaviors; however, acute administration of Asian
ginseng at high doses has been shown to decrease anxiety levels (Carr et al., 2006; Einat,
2007). Also, for the same reasons as testing anxiety levels we will test the rewarding or
aversive properties of NA ginseng.
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Chapter 2: North American ginseng improves erectile function and increases nitric
oxide synthase in penile tissue and hypothalamus of male rats.

2.1. Introduction

Erectile function is a complex interplay of physiological and psychological
factors. Prevalence of erectile dysfunction (ED) varies widely with select sample
populations but estimates range from 12% (Martin-Morales et al., 2001) to 22%
(Laumann et al., 1999) in men from 20 to 75 years of age. The prevalence of ED greatly
increases with co-morbid medical conditions and risk factors such as coronary artery
disease and diabetes (Rosen et al., 2004). Even though great advances have been made
towards ED treatment, only 58% of ED patients seek treatment and only 16% who are
prescribed phosphodiesterase type 5 (PDE5) inhibitors, such as Sildenafil, actively use
the drug (Rosen et al., 2004). In addition, not all men respond positively to PDE5
inhibitors, especially those with co-morbidities, and will discontinue its use when
expectations are not met (Azadzoi and Saenz de Tejada, 1992; Goldstein et al., 2003;
Jiann et al., 2006). Hence, there is continued need for additional ED treatments.

Ginseng has been used for millennia as a natural aphrodisiac. The two most
common species of ginseng are Panax ginseng (Asian ginseng) and Panax quinquefolius
(North American [NA] ginseng). Both species have unique ginsenoside profiles (Wan et
al., 2007; Sun et al., 2011), which are the main active constituents. Several studies have
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shown effects of Asian and Korean ginseng on male rat and mouse sexual behavior
(Murphy et al., 1998; Yoshimura et al., 1998; Choi et al., 1999). These studies have
shown decreases in mount and ejaculation latencies upon ginseng administration and
restoration of mating behavior in mice with copulatory disorders. Also, Asian ginseng
extracts have been shown to cause vasodilation in canine corpus cavemosum (Kang et
al., 2005), rabbit corpus cavemosum (Chen and Lee, 1995), as well as smooth muscle
cells in rat aorta (Kim et al., 1999). However, few studies have been conducted using NA
ginseng. In one study, chronic NA ginseng treatment facilitated sexual behavior in male
rats by decreasing mount, intromission, and ejaculatory latencies (Murphy et al., 1998).
The current study expanded on these previous findings by examining the effects of NA
ginseng, using two different extraction methods, on male sexual behavior in young adult
rats. In addition, effects on male erectile function and sexual arousal were examined in
models where an estrus female was physically inaccessible.

Finally, the third goal of the study was to elucidate potential sites of action by
which NA ginseng can improve sexual behavior. It has been well established that nitric
oxide (NO) is a major cellular mediator of erectile function via vasodilation in the corpus
cavemosum in penile tissue (Rajfer, 2008). NO activates soluble guanylate cyclase which
increases cyclic guanosine monophosphate (cGMP) levels, causing a cascade of events
leading to relaxation of smooth muscle cells and tumescence (Rajfer et al., 1992). It is
hypothesized that NA ginseng improves sexual function by increasing NO signalling in
erectile tissues. Indeed, ginsenoside Rgl, present in Asian and NA ginseng, increases NO
and cGMP levels in corpus cavemosum of male mice treated for 20 days (Wang et al.,
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2010b), which supports the hypothesis. Hence, effects of NA ginseng on expression of
nitric oxide synthase (NOS) in erectile tissue will be determined.

Moreover, NA ginseng may influence sexual behavior by acting on the central
nervous system. The central control of male erectile and sexual function derives from a
neural circuit including the paraventricular nucleus of the hypothalamus (PVN)
(McKenna, 2000; Giuliano and Rampin, 2004). In the PVN neuronal activation of
oxytocin neurons has been implicated with male erectile function (Argiolas and Melis,
2005). Neuronal nitric oxide synthase (nNOS) is required for the activation of oxytocin
neurons in the PVN (Melis et al., 1998). Effects of NA ginseng on the PVN have not yet
been established. Therefore, the final goal of this study was to examine effects of NA
ginseng on nNOS expression in the PVN.

30

2.2. Methods and Materials

2.2.1. Animals

Adult, male Long Evans rats (200-250 g) were delivered from Charles River
(Sherbrooke, Quebec, Canada) and housed in pairs in Plexiglas cages. Rats were placed
under a 12/12 reversed light-dark cycle with lights off at 10 a.m. Food and water were
available ad libitum. Female Long Evans rats (Charles River) were bilaterally
ovariectomized and subcutaneously implanted with a capsule containing 5% 17-|3estradiol benzoate (Sigma, St. Louis, Missouri, USA) and 95% cholesterol (Sigma, St.
Louis, Missouri, USA). To induce sexual receptivity, females were injected (s.c.) with
500 mg progesterone dissolved in 0.1 mL sesame oil (Sigma, St. Louis, Missouri, USA)
four hours prior to experiments. All procedures were approved by the Animal Care
Committee at the University of Western Ontario and conform to the guidelines of the
Canadian Council on Animal Care (Ottawa, Ontario, Canada).

2.2.2. North American Ginseng Extracts and Administration

Ginseng extracts were prepared from the roots of four-year-old NA ginseng plants
harvested from five farms in Ontario, Canada, which were provided by the Ontario
Ginseng Grower’s Association and processed by Naturex (South Hackensack, New
Jersey). Roots were ground and soaked at 40°C three times for a total of five hours in
either ethanol/water (75/25%) or aqueous solutions. The extracts were filtered and excess
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solvent was removed at 45°C until total solid content reached 60%. Ethanol and aqueous
NA ginseng root extracts were prepared after lyophilization at the Ontario Ginseng
Innovation and Research Consortium (University of Western Ontario, London, Canada).
The concentration of the major ginsenosides (Rbl Re, Rgl, Rb2, Rd, and Rc) for both
extracts have previously been determined by high-pressure liquid chromatography (Azike
et al., 2011).

Ginseng extracts were suspended in 0.9% saline and were injected daily to the rats
via oral gavage two to three hours after lights off under red light illumination. Rats were
randomly assigned to experimental groups and received one of two dosages of ethanol
extract (125 or 250 mg/kg/day) or aqueous extract (125 or 250 mg/kg/day) or vehicle
(0.9% saline). The volumes of all oral injections were adjusted so that less than 1 mL of
fluid was administered per day. Average weight of treatment groups did not differ at the
start of experiment. Male rats administered daily aqueous or ethanol extracts did not
differ in weight gain at any time point compared to control male rats administered saline
(data not shown).

2.2.3. Sex Behavior Analysis

Following 28 days of daily NA ginseng (ethanol or aqueous) or vehicle
administration, males were tested for sexual behavior every other day during four tests.
Males were sexually naive prior to onset of experiments, thus, effects of NA ginseng on
mating were determined in males when sexually naive and experienced. In addition,
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effects of NA ginseng on mating were determined either shortly following NA ginseng
administration or one day following last injection. For tests 1 and 3, males received NA
ginseng or vehicle 30 minutes prior to mating, while tests 2 and 4 were conducted 24
hours following last injection. During all tests, male rats were placed in a clean test cage
(with clean bedding; 60 x 45 x 50 cm3) 10 minutes prior to introduction of a receptive
female, and were allowed to mate to one ejaculation (and completed a post-ejaculatory
interval; PEI) or for one hour, whichever came first. All standard parameters of male
sexual performance were recorded including: mount latency (ML; time from introduction
of a female until the first mount), intromission latency (IL; time from introduction of a
female until the first mount with successful vaginal penetration), ejaculation latency (EL;
time from the first intromission of a female until ejaculation), PEI (time from ejaculation
to first subsequent intromission), number of mounts (M), and intromissions (IM) prior to
first ejaculation, and copulation efficiency (CE; ratio of number of intromissions to total
number of mounts). Differences between groups were compared using two-way ANOVA
(factors: test and treatment) and Student-Newman-Keuls t-test for post hoc analysis with
95% confidence levels (SigmaPlot version 11.0).

2.2.4. Non-Contact Erections

Next, following 36 days of daily NA ginseng or vehicle administration, male rats
(sexually experienced) were tested for non-contact erections (NCE); a paradigm for
psychogenic erections (Sachs and Garinello, 1978). The NCE apparatus consisted of two
same-sized compartments with clear walls, ceiling, and floors separated by a perforated
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screen (MED Associates Inc., St. Albans, Vermont, USA). Experimental design was
adapted from Sachs (Sachs, 1996). Briefly, males were habituated in the apparatus for
five minutes one day prior to testing. On the test day, male rats were injected with NA
ginseng 30 minutes prior to the experiment in the second half of the dark phase. Male rats
were then placed in one compartment with an estrus female in the other compartment. A
fan was placed behind the female to blow odors towards the male. The behavior was
recorded for 20 minutes using digital cameras (Samsung Seoul, South Korea; Sony,
Tokyo, Japan) and the latency to first erection and the number of erections were
measured. Erections were scored if the rat displayed one of three criteria: 1) visible
erection, or the male rat displays genital grooming with one of the two following
behaviors; 2) hip contractions or; 3) hip flexions. Differences between groups were
compared using one-way ANOVA and student t-tests for post hoc analysis with 95%
confidence levels.

2.2.5. Additional Behavioral Tests

Although the main goal of the study was to test the effects of NA ginseng on
sexual behavior and erectile function, additional tests were performed to determine
potential effects of NA ginseng on anxiety-like behaviors and to determine rewarding or
aversive properties. Moreover, ethanol or aqueous-treated animals were tested in
conditioned place preference (CPP) paradigm, elevated plus maze (EPM), and open field
tests between 2 to 3 weeks of NA ginseng or vehicle administration (prior to sex behavior
tests).
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2.2.5.I. Conditioned Place Preference Paradigm

Fourteen days after daily NA ginseng or vehicle injections, rats were tested for
rewarding or aversive properties of NA ginseng using the CPP paradigm as described by
Di Sebastiano et al. (Di Sebastiano et al., 2011). Briefly, the CPP apparatus (MED
Associates Inc., St. Albans, Vermont, USA), consisted of three chambers that differ in
visual and tactile cues: two test chambers (28 x 22 x 21 cm) with either black walls and
parallel bar flooring or white walls and metal grid flooring, and a central, neutral
compartment (13 x 22 x 21 cm) with grey walls and a smooth Plexiglas floor. Chambers
were connected by solid guillotine doors and equipped with photobeam arrays to record
time in each chamber. During the pre-test, male rats were allowed to freely roam the CPP
apparatus for 15 minutes to establish individual chamber preferences for each rat. The
apparatus is unbiased and, as a group, rats do not display a preference for any chamber.
Subsequently, during two conditioning days, rats received either NA ginseng or saline
and were placed in the paired (initially non-preferred) or unpaired (initially preferred)
chambers, respectively, for 30 minutes in a counter-balanced manner. During the post
test, rats were allowed to freely roam the apparatus for 15 minutes to determine a place
preference. A preference score (percentage of time spent in the ginseng-paired chamber)
and difference score (time in paired chamber minus time in unpaired chamber) was
calculated for each animal. Differences between pre- and post-tests scores were analyzed
using paired t-tests with 95% confidence levels.
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2 . 2 . 5 2 . Elevated Plus Maze (EMP)

After 24 days of daily NA ginseng or vehicle administration, male rats were tested
on the EPM (MED Associates Inc., St. Albans, Vermont, USA), 24 hours after last NA
ginseng or vehicle injection and during the second half of the light phase. The EPM
apparatus consisted of four arms elevated 75 cm from ground level, each 50 cm in length
extending from a central junction, equipped with photobeam arrays to record activity.
Two arms were enclosed by black siding 40 cm high, while the other two arms were
unenclosed. Male rats were placed in the center junction and allowed to roam the
apparatus for 5 minutes. Differences between groups were compared using one-way
ANOVA and student t-tests for post hoc analysis with 95% confidence levels.

2.2.5.3. Open Field

One day after the EPM test, rats were tested in an open field apparatus 24 hours
after last NA ginseng or vehicle injection and during the second half of the light phase.
Rats were placed in the open filed apparatus (40.5 x 40.5 cm; equipped with 16x16
photobeam arrays; MED Associates Inc., St. Albans, Vermont, USA) for 20 minutes.
Total ambulatory distance and resting time were recorded along the perimeter and in the
center of the chamber. Differences between groups were compared using one-way
ANOVA and Dunn’s Method for post hoc analysis with 95% confidence levels.

2.2.6. Tissue Collection
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After completion of all behavioral tests, brains, blood, and penile tissues were
collected to determine effects of NA ginseng on cellular mediators of erectile function.
Effects of aqueous extract were not determined, based on observed lack of effects of this
extract on sexual function (see results). Male rats chronically treated with NA ginseng or
vehicle received a final administration of vehicle or NA ginseng (250 mg/kg), creating
four groups. One hour later, males were anaesthetised with sodium pentobarbital (270
mg/mL/kg), and blood samples (collected in centrifuge tubes coated with heparin;
Pharmaceutical Partners of Canada Inc., Richmond Hill, ON, Canada) and penile tissue
were collected and immediately frozen and stored at -80 °C. Rats were then transcardially
perfused with 500 mL of 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer. Brains
were removed and post-fixed for one hour in PFA and then subsequently transferred to
20% sucrose solution. Brains were cut coronally at 35 pm on a freezing microtome
(Thermo Fisher Scientific, Walldorf, Germany) and collected in four parallel series in
cryoprotectant solution (30% sucrose in 0.1 M PB with 30% ethylene glycol and 0.01%
sodium azide) and stored at -20°C.

2.2.7. Immunohistochemistry

All procedures were performed under gentle agitation at room temperature.
Sections were washed in 0.1 M saline-buffered sodium phosphate (PBS) between all
incubation steps. Sections were incubated in H2 O2 (1% in PBS; 10 minutes), incubation
solution (PBS solution containing 0.1% bovine serum albumin (BSA; Fisher Scientific,
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Fair Lawn, New Jersey, USA) and 0.4% Triton-X-100 (Fisher Scientific, Fair Lawn, New
Jersey, USA); 1 hour), and then in primary antibody recognizing nNOS (rabbit antinNOS; Lot #24287; 1:40,000, DiaSorin, Saluggia, Italy) dissolved in incubation solution
for 17 hours.

Next, sections were incubated with biotinylated goat anti-rabbit (1:500 in
incubation solution, Vector Laboratories, Burlingame, CA, USA; 1 hour) and avidin
horseradish peroxidase complex (ABC; 1:1,000 in PBS, Vector Laboratories; 1 hour).
Reaction product was visualized with nickel-enhanced diaminobenzidine (DAB; 0.02%
in 0.1 M PB containing 0.012% H20 2 and 0.08% nickel sulfate; Sigma, St. Louis, MO;
10 minutes). Finally, sections were mounted on plus-charged glass slides (Fisher
Scientific, Fair Lawn, New Jersey, USA) and coverslipped with dibutyl phthalate xylene
(DPX; Electron Microscopy Science, Hatfield, PA, USA).

2.2.8. Densitometry analysis for nNOS

nNOS immunoreactivity was analyzed bilaterally in the PVN (Bregma -1.80mm,
nNOS: 1248 x 946 pixels). All images were taken under brightfield illumination using
Optronics camera (Optronics Goleta, California, USA) and Neurolucida software. All
images were taken together under the same magnification (using 20x objectives) and
camera settings. Each area of analysis was defined using unique landmarks specific for
the region (Paxinos and Watson, 1998). Density analyses of immunoreactive neurons
were measured by calculating a threshold based on a mean gray value of all the images
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and then determining the number of pixels above the threshold, expressed as the
percentage of the analyzed area using ImageJ (National Institute of Health, Bethesda,
MD, USA). For each brain region analysed, two images were analyzed and averaged per
animal. Differences between groups were compared using two-way ANOVA (factors:
chronic treatment and last injection) and Student-Newman-Keuls for post hoc analysis
with 95% confidence levels.

2.2.9. RNA isolation and real time PCR

Penile tissues from Long Evans male rats were homogenized in TriZol reagent
(Invitrogen, Burlington, Ontario, Canada) for total RNA isolation. To establish the
260/280nm absorbance ratio between 1.8 and 2.0, RNA quantity and purity were assessed
using a NanoDrop spectrophotometer (ND 1000 v3.3.0; NanoDrop Technologies, Inc.,
Wilmington, DE). High Capacity cDNA Reverse Transcription Kit from Applied
Biosystems Inc. was used to perform cDNA synthesis according to manufacturer’s
instructions (Foster City, CA). nNOS and eNOS gene expression were then quantified by
qRT-PCT. All reactions contained 2pL o f cDNA, lOpL of TaqMan Universal PCR
Master Mix 2X (Applied Biosystems, Foster City, CA), 0.8pL of 25mM MgCl2
(Invitrogen, Burlington, ON), 6.2pL DEPC treated water and lpL of TaqMan gene
expression assay solution for the gene of interest (nNOS Assay ID: Rn00583793_ml;
eNOS Assay ID: Rn02132634_sl). Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (Assay ID: Rn99999916_sl) was used for an endogenous control. Samples
were assayed in triplicate using the Rotor Gene RG 6000 Thermocycler and software
(Corbett Life Sciences, San Francisco, CA) with cycling conditions of: hold at 50°C for 2
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min and 95°C for 10 min, 40 cycles of 95°C for 15 sec and 58°C for 1 min. A standard
curve was generated from qRT-PCR data for each gene to quantify gene expression.
Penile cDNA reverse transcribed from RNA was used to create a standard curve with 5log serial dilutions. Optimal standard curves were achieved only when the line of best fit
of cycle threshold (C,) values of dilutions had a R2> 0.99 and an efficiency value
between 0.8-1. Each gene's optimal threshold line from the standard curve was used to
determine the Ct value of each sample, which were determined from the intersection
between the baseline subtracted amplification curve of the sample and the threshold line
established by the optimal standard curve. For each experiment sample, the Ct value for
each gene of interest was normalized to their respective Ct value of GAPDH, thus,
generating the ACt value. In addition, AACt values (= 2A(ACt(Sampie) - ACt(average))* 100)
were calculated using the difference between the ACt value for each individual sample in
the treatment groups and the average ACt value of the control group. Two-way ANOVA
with Holms Sidak post hoc analysis were conducted to identify significant differences
between groups. Values were considered significantly different with 95% confidence
levels.
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2.3. Results

2.3.1. Sexual Behavior

Administration of ethanol extract of NA ginseng significantly affected expression
of sexual behavior. There was a significant effect of treatment on the numbers of mounts
and intromissions, copulation efficiency, and inter-intromission interval (F(2,209)=3.3166; p=0.041-0.001) (Figure 2.1). Effects of trials were not detected for these
parameters of sex behavior except for number of intromissions (F(3, 209)=3.8; p=0.011).
Post hoc analyses revealed that number of mounts were significantly lower following
treatment of either of the two dosages compared to saline in mating trails 1 (p=0.0130.009), 2 (p= 0.032-0.038), and 4 (p=0.03-<0.001). Number of intromissions were higher
in trial 3 in the higher dosage group (p=0.017-0.022 ) and in trial 4 in the lower dosage
group (p=0.019) compared to saline controls. Ethanol extract of NA ginseng improved
the copulation efficiency in both low and high dosage groups compared to saline controls
in trials 1 (p=0.041-0,029), 2 (p=0.013-0.01) and 4 (p=0.048-0.005). Finally, inter
intromission interval was shorter in both lower and higher dosage groups compared to
saline, but only in trial 1 (p=0.016-0.005) (Table 2.1). In contrast to the effects observed
following chronic administration of the ethanol extract, the aqueous extract of NA
ginseng did not affect male sexual behavior. No significant effects of treatment were
detected for any of the parameters analyzed (Figure 2.1 and Table 2.1). Thus, ethanol, but
not aqueous, extract of NA ginseng improved copulation efficiency by decreasing
number of mounts and increasing number of intromissions.
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2.3.2. Non Contact Erections

Chronic administration of ethanol or aqueous extracts of NA ginseng did not
affect erectile function as analyzed in the NCE test as there were no changes in the total
number of erections or the timing to the first erection compared to control (Table 2.2).

2.3.3. Other behavioral tests

The rewarding or aversive properties of NA ginseng were tested with the CPP
paradigm. Ethanol extract had rewarding properties as male rats displayed an increased
preference during the post-test for the chamber of the CPP apparatus that was paired with
the higher dose of NA ginseng ethanol extract as indicated by a increased preference
score (p=0.009) and decreased difference score (p=0.005) (Figure 2.2A,B). The aqueous
extract did not affect CPP parameters, hence did not have rewarding nor aversive
properties (Figure 2.2C,D).

To determine if chronic NA ginseng administration affects general levels of
anxiety, animals were tested for anxiety-like behavior using EPM and open field tests.
Neither ethanol nor aqueous extracts of NA ginseng affected EPM parameters (Table
2.3). Similar results were observed in the open field test and neither ethanol nor aqueous
extracts affected distance moved or time spent in the center of the open field. The higher
dose of ethanol extract did, however, increase active time in the perimeter of the chamber
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compared to control (p<0.05), suggesting an effect on locomotor activity, rather than
anxiety-like behavior (Table 2.4).

2.3.4. Penile eNOS and nNOS mRNA

Administration of ethanol extract of NA ginseng resulted in increased eNOS
(Figure 2.3A) and nNOS (Figure 2.3B) mRNA expression in penile tissue. There was no
effect of chronic treatment, but rather of the last injection the animals received prior to
tissue collection (F(l, 20)=6.898; p=0.018). Hence, a final administration ofNA ginseng
in males chronically treated with NA ginseng or saline caused increased eNOS and nNOS
mRNA compared to saline controls.

2.3.5. Brain nNOS expression

In the PVN, ethanol extract of NA ginseng increased nNOS immunoreactivity
(Figure 2.4). Similar to the effects observed in penile tissue, there was no effect of
chronic administration but rather of the final injection of NA ginseng prior to tissue
collection (F(l,19)= 5.448; p=0.033). NA ginseng significantly increased nNOS
expression compared to saline controls in animals chronically treated with either NA
ginseng or saline.
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Figure 2.1. Effects of ethanol (A,B,C) and aqueous (D,E,F) extracts of NA ginseng on
number of mounts (A,D), number of intromissions (B,E), and copulation efficiency
(mounts/intromission) (C,F). Behavior was examined 30 minutes (tests 1 and 3) or 24
hours (tests 2 and 4) after last NA ginseng or vehicle injection. Number of animals per
group: Ethanol extract: control: n = 19, 125 mg/kg: n = 18, 250 mg/kg: n = 19; Aqueous
extract test 1 and 2: control: n = 18, 125 mg/kg: n = 7, 250 mg/kg: n = 18; Aqueous
extract test 3 and 4: control: n = 9, 250 mg/kg: n = 9. Data are presented as mean ± SEM.
* indicates significance from control within each test.

Table 2.1. Effects of ethanol and aqueous extracts of NA ginseng on latencies to mount
(ML), intromit (IL), or ejaculate (EL), post-ejaculatory interval (PEI), and inter
intromission interval (I IM I). All data are expressed in seconds. Behavior was examined
30 minutes (test 1 and 3) or 24 hours (test 2 and 4) after last NA ginseng or vehicle
injection. Number of animals per group: Ethanol extract: control: n = 19, 125 mg/kg: n =
18, 250 mg/kg: n = 19; Aqueous extract test 1 and 2: control: n = 18, 125 mg/kg: n = 7,
250 mg/kg: n = 18; Aqueous extract test 3 and 4: control: n = 9, 250 mg/kg: n = 9. Data
are presented as mean ± SEM. * indicates significance from control within each test.
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Test
Ethanol
Control

1
ML
157.1 ±48.8
IL
158.9 ± 48.7
EL
412.9 ± 79.7
PEI
342.8 ± 13.8
I IMI 40.9 ± 4.0
172.6 ±48.8
125 mg/kg ML
179.3 ±48.7
IL
EL
349.9 ±45.1
PEI
280.1 ±20.1
I IMI 34.1 ±3.3*
250 mg/kg ML
68.0 ± 13.6
IL
75.6 ± 15.1
357.9 ± 52.2
EL
PEI
296.5 ± 13.8
I IMI 34.8 ±4.0*
Aqueous
Control

ML
IL
EL
PEI
I IMI
125 mg/kg ML
IL
EL
PEI
I IM I
250 mg/kg ML
IL
EL
PEI
I IMI

98.6 ±28.3
101.9 ± 28.8
467.5 ±58.1
308.2 ± 16.3
39.4 ± 4.9
52.7 ±23.7
56.3 ± 23.4
372.4 ± 50.9
309.7 ± 5 .9
33.5 ±3.1
156.4 ± 39.4
234.8 ± 59.4
478.7 ± 60.5
356.3 ± 20.2
43.5 ± 4 .9

2
67.2 ± 21.9
78.4 ± 22.2
529.3 ± 75.3
330.3 ± 18.2
39.1 ± 5 .8
108.2 ±21.9
122.2 ± 45.9
469.1 ±73.5
302.3 ± 14.2
41.5 ± 7 .0
99.3 ± 47.4
123.2 ±50.5
475.8 ± 72.8
324.7 ± 18.2
33.5 ± 5.8

3
38.1 ± 11.0
39.5 ± 10.9
416.1 ± 80.7
380.1 ±30.1
42.2 ± 7.9
39.2 ±21.5
45.1 ± 21.6
305.3 ±45.1
328.8 ± 12.3
28.3 ±3.1
22.1 ± 4 .2
23.8 ± 5.3
627.4 ± 145.0
380.8 ±30.1
34.2 ± 7.9

4
21.8 ± 2 .9
26.2 ± 3 .9
638.4 ± 113.2
392.5 ± 25.2
34.9 ± 3.7
65.2 ± 2 .9
66.1 ±39.1
360.2 ± 53.4
331.8 ± 15.5
32.4 ±3.1
25.2 ± 5 .4
29.4 ± 5.5
349.7 ± 45.4
372.6 ±25.2
23.6 ± 3 .7

93.4 ± 43.7
93.4 ± 43.7
480.1 ±69.1
367.2 ± 47.9
37.8 ± 5 .9
15.1 ± 4 .9
20.7 ± 6.3
524.7 ± 113.8
304.9 ± 22.4
27.8 ± 11.8
163.4 ±72.9
202.9 ± 73.0
553.9 ± 160.6
334.1 ± 19.7
49.0 ± 10.2

210.5 ± 149.1
218.3 ± 148.2
300.2 ± 46.4
326.6 ± 16.6
28.3 ±3.1

182.6 ±42.8
183.1 ±42.9
497.1 ± 129.7
404.0 ± 78.7
42.1 ± 5.2

43.3 ± 15.8
43.7 ± 15.7
389.6 ±94.7
343.4 ± 19.8
27.6 ± 4 .6

52.3 ± 14.9
74.6 ±23.4
395.8 ±90.4
399.0 ±26.6
30.1 ± 3 .9
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Table 2.2. Effects of ethanol extract of NA ginseng on number of non-contact erections
(NCE) and timing to first NCE over a test period of 20 minutes. Number of animals per
group: control: n = 20, 125 mg/kg n = 19, 250 mg/kg n = 20. Data are presented as mean
± SEM. No significant differences between groups were detected.

Control
125 mg/kg
250 mg/kg

Ethanol
Aqueous
Number of
Time to First
Number of
Time to First
Erections______ Erection (secs) Erections______ Erection (secs)
1.63 ±0.42
1.20 ±0.30
713.1 ±82.1
584.1 ±76.31
571.5 ±62.6
1.38 ±0.50
732.2 ± 136.4
1.74 ±0.31
1.60 ±0.32
571.1 ±55.7
2.00 ±0.93
532.2 ± 105.6
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Figure 2.2. Conditioned Place Preference (CPP) data for two doses of ethanol (A,B) or
aqueous (C,D) extracts of NA ginseng. Animals received NA ginseng approximately 24
hours prior to testing. Data are presented as a preference score (A,C; percentage of time
spent in paired chamber as a ratio of paired and unpaired chambers) and difference score
(B,D; time spent in paired minus unpaired chamber) during the pre- (white bars) and
post-test (black bars). Numbers of animals per group: Ethanol extract: control: n = 20,
125 mg/kg: n = 19, 250 mg/kg: n = 21; Aqueous extract: control: n = 9, 125 mg/kg: n = 8,
250 mg/kg: n = 7. Data are presented as mean ± SEM. * indicates significant difference
from pre-test.
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Table 2.3. Effects of chronic administration of ethanol and aqueous extracts of NA
ginseng on behavior in the elevated plus maze (EPM). Data are presented as mean ± SEM
of the percent of time spent in open or closed arms and the number of entries into the
open or closed arms of the EPM apparatus during a five minute test period. Numbers of
animals per group: Ethanol extract: control: n = 19, 125 mg/kg: n = 18, 250 mg/kg: n =
21; Aqueous extract: control: n = 9, 125 mg/kg: n = 8, 250 mg/kg: n = 7. No significant
differences between groups were detected.

# of Entries

Percent of Time
Ethanol

Aqueous

Open

Closed

Open

Close

Control
125 mg/kg
250 mg/kg

23.00 ±2.72
28.17 ± 1.56
27.97 ±2.14

64.66 ± 3.50
61.44 ± 1.78

4.63 ± 1.05
4.06 ±0.51
4.10 ±0.50

10.42 ±0.97
9.83 ±0.78
11.43 ±0.82

Control
125 mg/kg
250 mg/kg

33.74 ±5.37
30.25 ±6.61
33.87 ±3.44

57.49 ±6.21

5.33 ± 1.30
4.63 ± 1.10
7.29 ± 1.02

12.44 ± 1.39
11.38 ±0.75
11.57 ± 1.66

59.66 ± 2.64
61.13 ± 7.71
52.61 ±4.11
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Table 2.4. Effects of chronic administration of ethanol and aqueous extracts ofNA
ginseng on behavior in an open field test. Data are presented as mean ± SEM of the
ambulatory distance and the time the animal was active in the center and perimeter of the
apparatus during a twenty minute testing period. Numbers of animals per group: Ethanol
extract: control: n = 20, 125 mg/kg: n = 19, 250 mg/kg: n = 22; Aqueous extract: control:
n = 9, 125 mg/kg: n = 8, 250 mg/kg: n = 7. * indicates significance from control.

Ethanol

Aqueous

Ambulatory Distance (cm)

Active Time (secs)

Center

Perimeter

Center

Perimeter

Control

277.9 ±35.6

2355 ± 140

115.6 ± 14.9

875.8 ±71.6

125 mg/kg

229.2 ±25.7

2243 ± 164

92.58 ± 11.7

825.0 ±69.5

250 mg/kg

328.0 ±24.6

2671 ± 97

129.8 ± 10.6

1020 ±42.3*

Control
125 mg/kg
250 mg/kg

300.9 ±48.4
280.0 ± 40.2
367.6 ±60.3

2942 ± 264
2501 ±225
2507 ± 245

121.1 ±18.1
136.6 ±31.7
137.6 ±24.4

1106 ± 114.9
957.6 ± 103.5
884.4 ± 113.3

52

A m
*
io»> •
Q 4$$ *
09

c

5 m '
2Cm>*
lil^ 0 J—l----Chronic

Sains

Ctiranic

Saline

Ghsa'vg

Saline

Ginseng

Lbs!

Desire

Last

Salne

Dalits

G*rse^c

Ginseng

/
Figure 2.3. Effects of ethanol extract of NA ginseng on mRNA expression of eNOS (A)
and nNOS (B) in penile tissue. Males were treated chronically with saline or NA ginseng
(250 mg/kg) and received vehicle or NA ginseng (250 mg/kg) 1 hour prior to tissue
collection, n = 5 (groups: saline/saline, ginseng/saline, saline/ginseng) or n=6
(ginseng/ginseng group). Data are presented as mean ± SEM. * indicates significant
difference between groups last treated with NA ginseng compared to saline.
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Figure 2.4. Effects of ethanol extract of NA ginseng on nNOS immunoreactivity in the
paraventricular nucleus of the hypothalamus (PVN). A is a schematic drawing of area of
analysis (Paxinos and Watson, 1998); 3V: third vetricle; fx: fomix; ot: optic tract. B
illustrates the quantitative densitometry analysis showing percentage of the area of
analysis that is above threshold in males chronically treated with saline or NA ginseng
(250 mg/kg) and received vehicle or NA ginseng (250 mg/kg) 1 hour prior to tissue
collection, n = 5 for all groups. Data are presented as mean ± SEM. * indicates significant
difference between groups last treated with NA ginseng compared to saline. C and D
show representative images of nNos immunoreactivity in the PVN of males treated with
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saline and receiving saline (C) or NA ginseng (D) during the last injection. Scale bar
indicates 50 p.m.
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2.4. Discussion

The results of this study show that administration of NA ginseng results in
facilitation of sexual behavior in adult, male rats. In particular, ethanol extract of NA
ginseng improved copulation efficiency, which is indicative of improved erectile function
(Clark, 1995). These effects on erectile function were only noted when animals were
tested in a mating context and were not observed when males were not in direct contact
with an estrus females. NA ginseng ethanol extract may modulate erectile function by
increasing expression of nNOS and eNOS in erectile tissues and nNOS in the PVN;
however other unknown pathways are involved.

The effects of ginseng on male sexual behavior have been reported in rats (Kim et
al., 1976; Murphy et al., 1998; Wang et al., 2010b), mice (Yoshimura et al., 1998),
rabbits (Chen and Lee, 1995; Choi et al., 1999) and humans (Hong et al., 2002; de
Andrade et al., 2007; Jang et al., 2008; Kim et al., 2009). The majority of these studies
were conducted using extracts of Asian ginseng or its processed form known as Korean
Red ginseng, which is the steamed root of Asian ginseng. Human studies have shown
improved male erectile ability as indicated by physiological tests on penile rigidity and
self-reporting scores on penetration, erection maintenance, and rigidity using the
International Index of Erectile Function (IIEF) (Hong et al., 2002; de Andrade et al.,
2007; Jang et al., 2008; Kim et al., 2009). The animal studies on ginseng have shown a
propensity to induce vasodilation in erectile tissue that will cause an erection and
improve male sexual performance (Kim et al., 1976; Choi et al., 1999). Other studies
have used ginsenoside extracts, rather than full root extracts, to test the effects on sexual
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behavior (Yoshimura et al., 1998; Wang et al., 2010b). Ginsenosides are considered the
main active constituents of the ginseng genus (Leung and Wong, 2010; Wang et al.,
2010a; Tsutsumi et al., 2011; Yin et al., 2011). Previous studies have identified Rgl as a
main contributor to enhancing male sexual behavior with little to no contribution from
ginsenosides Rbl or Rb2 (Yoshimura et al., 1998; Wang et al., 2010b). Much less is
known about the effects of other ginseng species, such as NA ginseng, on male sexual
behavior. The only previous study on male sexual behavior with NA ginseng
demonstrated an increase in sexual performance indicated by decreased latencies to
mount, intromission, and ejaculation (Murphy et al., 1998). The current study did not
demonstrate effects of NA ginseng on measures of motivation. Rather, it was shown that
NA ginseng facilitates male sexual behavior by improving copulation efficiency and
reducing number of mounts prior to ejaculation. These parameters reflect erectile
function (Clark, 1995). Hence, NA ginseng improved erectile function during mating.
Moreover, the effect of NA ginseng was evident in males that were sexually naive or
experienced.

The effects of NA ginseng appeared dependent on the context in which erectile
function was observed; i.e. it was improved during mating behavior but effects of NA
ginseng were not detected on NCE. NCE are considered a representation for erectile
function induced by arousal, which are called psychogenic erections in humans (Sachs
and Garinello, 1978). Potential explanations for the difference in facilitation of erection
include dosage of NA ginseng; effects with NCE may require higher dosages. In addition,
the lack of effects of NA ginseng on NCE may be related to differences in neural control
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of erections during mating compared to NCE. For example, lesions of the medial preoptic
area (mPOA) caused a large impairment in sexual performance during mating but had
minimal to no effects on NCE (Liu et ah, 1997a). The mPOA is essential for
orchestrating male sexual behavior and studies have shown its activation during sexual
behavior (Coolen et ah, 1996, 1998). In the same study mentioned above, Liu and
colleagues reported the reverse effect in the bed nucleus of the stria terminalis (BNST);
lesions mostly abolished NCE but had little effect on copulatory performance. The BNST
is a conduit for information between brain regions involved in male sexual behaviour and
is activated during appetitive and consummatory phases of copulation (Kondo and Arai,
1995; Coolen et ah, 1997). Consequently, NA ginseng may not affect the neural
substrates mediating NCE.

An objective of the current study was to differentiate any erectile enhancing
effects between two common extracts of ginseng: ethanol and aqueous, since different
effects of extract preparations have been reported on immunomodulation and the
cardiovascular system (Lee et ah, 1981; Azike et ah, 2011). Indeed, differing effects of
the two extracts were noted; improved erectile function occurred only with the
administration of ethanol extract and not with the aqueous extract of NA ginseng. Both
extracts have different ginsenoside profiles based on the solubility of the individual
ginsenosides (Azike et ah, 2011). The ethanol extract of the NA ginseng used in the
current study has a higher percentage of ginsenoside content (approximately 28% total
ginsenoside content by weight in ethanol extract compared to 14% in aqueous extract).
While ginsenoside Rbl has been shown not to have an effect on preventing male mice
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copulatory disorder when testing the latencies and frequencies of sexual behavior
parameters (Yoshimura et al., 1998), its ability on enhancing erectile function has not
been examined and cannot be ruled out in our study. Ginsenoside Rgl has been shown to
enhance sexual behavior (Yoshimura et al., 1998; Wang et al., 2010b); however, Rgl
concentrations did not significantly differ between extracts. As such, ginsenoside Rgl is
unlikely to account for differences in erectile enhancing effects seen between extracts.
Moreover, differences in extract effectiveness may be due to a minimum effective dose;
ginsenoside concentration in the aqueous extract may not be sufficient to induce an
effect. More studies are needed to determine which ginsenosides of NA ginseng are
active at improving erectile function. Finally, differences in extract effects may also be
due to polysaccharides (PS), which are found in NA ginseng. Although ginsenosides have
traditionally been seen as the principal active constituents of ginseng, studies show that
PS have active properties and are found in aqueous, not ethanol, extracts (Azike et al.,
2011). However, since aqueous extract was not effective in facilitating erectile function,
it is unlikely that PS are major contributors to the effects of ginseng on male sex function.

The mechanisms by which NA ginseng influences sexual behavior are unclear. It
has been proposed that ginseng affects the cellular mediators of erectile function in the
erectile tissues and/or testosterone synthesis (Chen and Lee, 1995; Choi et al., 1999;
Wang et al., 2010b). Ginseng extracts cause vasodilation in the vasculature as shown in
in vivo (Tsutsumi et al., 2011; Xu et al., 2011) and in vitro (Kang et al., 1995; Toda et
al., 2001; Tsutsumi et al., 2011) studies. Effects of ginseng on cellular mediators of
erectile function (Gratzke et al., 2010) have also been demonstrated. Concentration-

59

dependent vasodilatory effects of Asian ginseng in vitro using rabbit corpus cavemosum
(Chen and Lee, 1995) have been reported in addition to increased levels of cGMP in
ginseng-treated tissue. Chen and Lee acutely treated penile tissue with ginseng for 10
minutes and discovered an increase in the percent relaxation compared to control. Also,
ginseng has been shown to act at the vascular level on the NO/cGMP pathway to induce
erections. Chronic administration of Rgl ginsenoside extract increased cGMP and NO
levels in mice corpus cavemosum concomitant to improved sexual performance (Wang et
al., 2010b). The current study provides a potential target of an upstream effect of ethanol
extract of NA ginseng on the NO/cGMP pathway. NA ginseng ethanol extract increased
levels of both eNOS and nNOS in penile tissue. Unexpectedly, levels of nNOS and eNOS
mRNA were not up-regulated by chronic, but rather by acute administration of ethanol
extract. Previous studies have shown minute concentrations of ginsenosides in circulation
within 15 minutes after oral administration (Song et al., 2010). Furthermore, ginseng
extracts have been demonstrated to induce NO-mediated relaxation of rabbit corpus
cavemosum and increased cGMP levels after only 10 minutes of exposure (Chen and
Lee, 1995). Hence, it is possible that NA ginseng increases eNOS and nNOS mRNA in
the corpus cavemosum one hour after injection, which can lead to an increase in cGMP
content in smooth muscle cells. However, the increase in nNOS and eNOS mRNA does
not appear to be required for the facilitative effects of NA ginseng on erectile function, as
chronic administration of ginseng altered sexual function without altering mRNA levels
for nNOS or eNOS in penile tissue.

Another potential mediator of the effects of ginseng on sexual function is the
steroid hormone testosterone. Chronic ginsenoside Rgl exposure has been shown to
result in increased levels of testosterone in plasma of male mice (Wang et al., 2010b). In
contrast, another study using NA ginseng detected no effects on testosterone levels
(Murphy et al., 1998). As such, further studies are needed to determine if NA ginseng has
any effect on hormone levels in animals and in humans.

Ginseng may influence sexual function by acting on the brain. Hence, the current
study tested if ethanol extract of NA ginseng influenced brain areas that mediate erectile
function such as the PVN (McKenna, 2000). The PVN is an integration center involved
in many autonomic processes (Argiolas and Melis, 2005). The role of the PVN in male
erectile function has been well established through studies showing stimulation induces
penile erection (Melis et al., 1994; Chen and Chang, 2002, 2003) and bilateral lesions
greatly reduces the ability to obtain an erection (Argiolas et al., 1987; Liu et al., 1997b).
A role for oxytocinergic neurons in the PVN in the control of penile erection in the male
rat has been implicated (Argiolas and Melis, 2004). In turn, PVN oxytocin neurons are
influenced by endogenous NO production by nNOS to cause release of oxytocin in extrahypothalamic brain regions and the spinal cord (Melis et al., 1996; Melis and Argiolas,
1997; Melis et al., 1997).

The current study demonstrated an increase in nNOS immunoreactivity in the
PVN of rats treated with ethanol extract of NA ginseng one hour before sacrifice.
Chronic administration did not influence nNOS immunoreactivity. Similar to the penile
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tissue, the increase in nNOS in the PVN does not appear to be required for the facilitative
effects of NA ginseng on male sexual behavior. These data suggest that NA ginseng may
influence erectile function via increased nNOS expression; in turn possibly activating
oxytocin projections from the PVN. However, chronic administration of NA ginseng
enhanced sexual behavior during copulation, however, did not influence nNOS in the
PVN. As such, alternate mechanisms of action exist for the ethanol extract of NA ginseng
to enhance erectile function besides those detected in the current experiment.

Finally, the current study shows that ethanol extract of NA ginseng has rewarding
properties since males formed a conditioned place preference, a widely used test for
reward-seeking behavior (Tzschentke, 2007). Also, ginseng has also been indicated to be
anxiolytic (Carr et al., 2006). In the previous study, anxiety behaviors were tested
immediately following Asian ginseng administration at high dosing levels; however, the
current study tested animals after approximately 24 hours after last injection and used
lower doses of NA ginseng. As such, the lack of anxiolytic effects of our study may be
due to timing of injection prior to testing and the doses used. Indeed, studies have shown
that chronic Asian ginseng administration at doses similar to those used in our
experiment do not have anxiolytic properties (Einat, 2007). Therefore, anxiolytic effects
of ginseng may only be detected shortly after consumption and may not be long lasting.

In conclusion, this study shows that ethanol, but not aqueous, extract of NA
ginseng increased erectile function in male rats during mating behavior. NA ginseng
effects are potentially mediated through eNOS and nNOS mRNA in penile tissue and
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nNOS density in the PVN; however, other mechanisms of action contribute to its proerectile effects seen during chronic treatment, which are yet to be discovered.
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Chapter 3: North American ginseng improves erectile function in Obese Zucker
rats.

3.1. Introduction

Erectile dysfunction (ED) is a serious disorder that decreases the quality of life in
men and their partners (Vickers and Wright, 2004). ED may occur by various alterations
in physiology. It has been well established that nitric oxide (NO) is the main cellular
mediator of erectile function, causing vasodilation in the corpus cavemosum in penile
tissue (Awad et al., 2011). Type 2 Diabetes Mellitus (T2DM) patients experience many
physiological alterations that predispose them to ED such as decreased neuronal nitric
oxide synthase (nNOS) expression (Xie et al., 2007) and increased reactive oxygen
species (ROS) that scavenge for NO in vasculature and decrease its availability to
vasodilate corpus cavemosum (De Young et al., 2004; Yan et a l, 2008). While under
10% of the general male population experiences some form or ED, men with T2DM have
a prevalence rate of approximately 28% (Feldman et al., 1994). In addition, only 56% of
men with T2DM respond to phosphodiesterase type 5(PDE5) inhibitors as compared to
87% of the general population (Rendell et al., 1999). Moreover, men who responded
positively to PDE5 inhibitors may revert back to pre-treatment conditions (Penson et a l,
2003). Hence, development of additional pharmacological treatments is needed.

In the current study, North American (NA) ginseng was examined as a potential
treatment for ED. The two most common species in the ginseng genus are Panax ginseng
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(Asian ginseng) and Panax quinquefolius (North American ginseng). Extracts of Asian
ginseng and Korean Red ginseng, created when Asian ginseng is steamed, have been
shown to facilitate male sexual behavior (Yoshimura et al., 1998; Choi et al., 1999; Hong
et al., 2002; de Andrade et al., 2007; Kim et al., 2009) and to cause vasodilation in
corpus cavemosum (Chen and Lee, 1995; Kang et al., 2005). In addition, NA ginseng has
been shown to enhance erectile function and sexual performance in male rats (Murphy et
al., 1998; Barnes et al., 2011).

Ginsenosides are triterpenoid glycosides, also called saponins, and are considered
the principal active constituents in ginseng (Attele et al., 1999; Leung and Wong, 2010).
Ginsenosides have been shown to reduce glucose levels in blood (Ji and Gong, 2007) and
increase glutathione and decrease markers of lipid peroxidation (Ryu et al., 2005). Hence,
NA ginseng may restore some of the underlying physical alterations associated with
T2DM that contribute to ED development.

The current study tested if NA ginseng improves erectile function using Obese
Zucker (OZ) rats as a pre-diabetic model for T2DM, as T2DM accounts for 90-95% of
diabetic patients (Hidalgo-Tamola and Chitaley, 2009). OZ rats have an autosomal
recessive mutation in the leptin receptor gene (Kasiske et al., 1992), and represent a less
severe model of ED caused by diabetic complications than a model with complete
diabetes such as the Zucker Diabetic rat (Garcia et al., 2009). Also, similar to T2DM
patients, OZ rats have hyperinsulinemia, insulin resistance, glucose intolerance,
hyperlipidemia, obesity, hypertension, and impaired vasodilation (Kasiske et al., 1992).
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This study examines the effects of NA ginseng on mating behavior, penile reflexes, and
cellular mediators of erectile function in penile tissue of OZ rats.
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3.2. Methods and Materials

3.2.1. Animals

Adult male OZ (250-300 g) and Lean Zucker (LZ) (200-250 g) rats were obtained
from Charles River (Sherbrooke, Quebec, Canada). Rats were housed in pairs in standard
Plexiglas holding cages, under a 12/12 light-dark cycle (lights off at 10 a.m.) with food
and water available at all times. Female Long Evans rats (200-225 g; Charles River) were
bilaterally ovariectomized and subcutaneously implanted with a capsule containing 5%
17-P-estradiol benzoate (Sigma, St. Louis, Missouri, USA) and 95% cholesterol (Sigma,
St. Louis, Missouri, USA). Sexual receptivity in females was induced on test days with a
subcutaneous injection of 500 mg progesterone dissolved in 0.1 mL sesame oil (Sigma,
St. Louis, Missouri, USA) four hours prior to experiments. All procedures were approved
by the Animal Care Committee at the University of Western Ontario and conform to the
guidelines of the Canadian Council on Animal Care (Ottawa, Ontario, Canada).

3.2.2. North American Ginseng Extracts and Administration

Roots of NA ginseng from five farms in Ontario, Canada were harvested after
four years of growth by the Ontario Ginseng Grower’s Association. Roots were
processed by Naturex (South Hackensack, New Jersey) by grinding and soaking them at
40°C, three times for a total of five hours in either 75% ethanol or aqueous solutions. The
ethanol or aqueous extracts were filtered and heated at 45 °C to remove excess solvent to
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produce 60% total solid content. Ethanol and aqueous NA ginseng root extracts were
prepared after lyophilization at the Ontario Ginseng Innovation and Research Consortium
(University of Western Ontario, London, Canada). Concentration for the major
ginsenosides (Rbl Re, Rgl, Rb2, Rd, and Rc) in both extracts have previously been
determined by high-pressure liquid chromatography (Azike et al., 2011).
Saline (0.9%) was used to suspend the powdered NA ginseng ethanol or aqueous
extracts and rats were injected daily with either extract (250 mg/kg) or vehicle (saline)
via oral gavage two to three hours after lights off under red light illumination unless
otherwise stated for test days. Concentration of each injection was adjusted based on the
weights of the animals so all injection volumes were less than 1 mL per day.

3.2.3. Experimental design

In the first experiment, untreated OZ and LZ rats (n = 10) were tested for sexual
behavior every other day for three tests. In the second experiment, a separate group of OZ
rats were treated with ethanol or aqueous NA ginseng extracts or vehicle (n = 12 for
saline and aqueous groups, n = 13 for ethanol group) and tested for sexual behavior in a
series of four tests every other day after 28 days of daily NA ginseng or vehicle
administration. Subsequently, these males were tested for erectile function using ex
copula tests. Throughout the experiment, males were weighed every two days prior to
injection. Average weight of treatment groups did not differ at the start of the experiment.
For each animal body weights were expressed as a percentage of the initial body weight
at start of the experiment. Differences between groups were analyzed using repeated
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measures ANOVA (factors: time and treatment) and Student-Newman-Keuls for post hoc
analyses with 95% confidence levels (SigmaPlot version 11.0).

3.2.4. Sex Behavior

Tests occurred every other day for a total of three (untreated OZ and LZ rats;
experiment 1) or four (treated OZ rats; experiment 2) tests. Male rats were sexually naive
prior to the start of the tests. As such, effects of treatment on sexual behavior were
determined in the rats while naive and sexually experienced. In experiment 2, at the start
of the experiment, weights of the groups were measured for appropriate dosing. In
addition effects of NA ginseng treatment were tested either 30 minutes or 24 hours
following last drug administration; for tests 1 and 3 rats received NA ginseng 30 minutes
prior to mating while during tests 2 and 4 rats received NA ginseng 24 hours prior to
testing. As such, testing examined acute and chronic effects of NA ginseng dosing.
During all tests, rats were placed in a clean test cage (60 x 45 x 50 cm3) ten minutes prior
to introduction of a receptive female. Male rats were allowed to mate to either one
ejaculation (and completed post-ejaculatory interval; PEI) or for one hour, whichever
came first. All standard parameters of male sexual performance were recorded including:
mount latency (ML; time from introduction of receptive female until the first mount),
intromission latency (IL; time from introduction of receptive female until the first mount
with successful vaginal penetration), ejaculation latency (EL; time from the first
intromission until ejaculation), PEI (time from ejaculation to first subsequent
intromission), numbers of mounts and intromissions (M and IM) prior to ejaculation,
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copulation efficiency (CE; ratio of number of intromissions to total number of mounts
plus intromissions), and inter-intromission interval (I IM I; testing period divided by
number of intromission). Because few OZ rats ejaculated within one hour, all animals
were included in the analysis if they performed at least one mount (approximately 50% in
naive rats and up to 90% by final test); no values for latencies were recorded unless the
rat performed the particular sex behavior parameter. In addition, when calculating I IM I,
if the rat intromitted but did not ejaculate then a value of 3600 seconds for EL was used
(duration of test). For both experiments, differences between groups were compared
using two-way analysis of variance (factors: trial and strain (LZ vs. OZ) or treatment (NA
ginseng vs. vehicle)) and all pairwise multiple comparison procedures with Holm-Sidak
method for post hoc analysis with 95% confidence levels.

3.2.5. E x Copula Tests

A testing apparatus consisting of a Plexiglas base fixed to a 12 inch tube was used
to restrain the rats in a supine position with the rat’s head and upper torso inside the tube
and lower torso and legs exposed. Rats were habituated to the apparatus and testing
position for 10 minutes for four consecutive days prior to testing. On test days, the penile
prepuce was retracted to allow measurements of penile reflexes (Sachs and Garinello,
1978) and rats were video recorded for 30 minutes if no erection occurred or for 15
minutes after the first erection. Rats received NA ginseng or saline 30 minutes prior to
testing. Videos were scored by an experimenter blinded to treatment groups and the
following measures were quantified: E l erections (base of glans engorges with blood),
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E2 erections (both tip and base of glans engorge with blood), E3 erections (cups; an E2
erection with flaring of the tip of the glans so that the diameter of the glans tip surpassed
the base), FI anteroflexions (ventral penile extension from resting position that is less
than 90 degrees from ventrum), and F2 anteroflexions (ventral penile extension from
resting position that surpasses 90 degrees from ventrum) (Sachs, 1985). Also, the latency
to the first erection and clusters of erections within 30 seconds (series of penile responses
occurring within a 30 second time period) were recorded (Sachs, 1985). Differences
between either the ethanol or aqueous group and control vehicle-treated group were
compared using Mann-Whitney Rank Sum tests with 95% confidence levels. Percentages
of animals displaying E3 erections were compared between groups using Chi-square
analysis.

3.2.6. Tissue Collection

Following completion of behavioral tests, animals received an overdose of
pentobarbital (270 mg/mL/kg) and blood, testes, and penile tissues were harvested. In
experiment 1, LZ and OZ rats were not treated prior to tissue collection. In experiment 2,
rats chronically treated with NA ginseng were administered either a final dose of NA
ginseng or vehicle one hour before sacrifice, thus, five treatment groups were created to
determine the effects of NA ginseng on cellular mediators of erectile function. Testes
were weighed at time of collection. Penile tissues were frozen at -80°C until processing
for real time PCR. Blood was collected in centrifuge tubes containing heparin
(Pharmaceutical Partners of Canada Inc., Richmond Hill, ON, Canada) and centrifuged at
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3000 rpm for 15min at 0°C (Beckman Model TJ-6 centrifuge attached to a TJ-R
Refrigeration Unit). Plasma was removed, aliquoted and stored at -80°C until further
processing for steroid assays.

3.2.7. Real time PCR

Penile tissues of untreated LZ and OZ, and NA ginseng or vehicle treated OZ males
were homogenized in TriZol reagent (Invitrogen, Burlington, ON) for total RNA
isolation. RNA quantity and purity were assessed using a NanoDrop spectrophotometer
(ND 1000 v3.3.0; NanoDrop Technologies, Inc., Wilmington, DE) to ensure that the
260/280nm absorbance ratio was between 1.8 and 2.0. cDNA synthesis was performed
using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems Inc.,
Foster City, CA) according to the manufacturer’s instructions. Following cDNA
synthesis, nNOS and eNOS gene expression was quantified by qRT-PCR. Each reaction
contained 2pL of cDNA, lOpL of TaqMan Universal PCR Master Mix 2X (Applied
Biosystems), 0.8pL of 25mM MgCl2 (Invitrogen), 6.2pL DEPC treated water, and lpL of
TaqMan gene expression assay solution for the gene of interest (nNOS Assay ID:
Rn00583793_ml; eNOS Assay ID: Rn02132634_sl). Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) (Assay ID: Rn99999916_sl) was used as an endogenous
control. Each sample was assayed in triplicate using the Rotor Gene RG 6000
thermocycler and software (Corbett Life Sciences, San Francisco, CA) at the following
cycling conditions: hold at 50°C for 2 min and 95°C for 10 min, 40 cycles of 95°C for 15
sec and 58°C for 1 min. Quantification of gene expression was calculated by use of a
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standard curve generated from qRT-PCR for each gene analyzed. cDNA reverse
transcribed from RNA isolated from penile tissue was used to create a standard curve
with 5-log serial dilutions. Standard curves were deemed optimal when the line of best fit
through the cycle threshold (Ct) values of the dilutions had a R > 0.99 and an efficiency
value between 0.8-1. An optimal threshold line generated from the standard curve for
each gene was used to determine the Ct value for each sample. The Ct of each experiment
sample was determined from the intersection between the baseline subtracted
amplification curve of the sample and the threshold line established by the optimal
standard curve. For each experiment sample, the Ct value for each gene of interest was
normalized to their respective Ct value of the housekeeping gene, GAPDH. This value
corresponds to the ACt value. Furthermore, the difference between the ACt value for each
individual sample in the treatment groups and the average ACt value of the control group
was calculated as the AACt value (= 2 A(A C t(Sampie) - AQaverage))* 100). One-way ANOVA
with Holms Sidak post hoc analysis were conducted to identify significant differences
between groups. Values were considered significantly different with/?<0.05.

Testosterone Analysis

All samples were assayed at the Core Assay Facility in the Department of
Psychology at the University of Michigan (Ann Arbor, Michigan). ELISA kits
specifically designed for measuring testosterone in mouse/rat serum or plasma were used
(Cat. # TE187S-100, Calbiotech Inc, USA). The reference for this ELISA ranged from
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0.1-18.0 ng/mL and 25 uL of standards, samples, and controls were analyzed in duplicate.
Absorbance was read at 450 nm with a microtiter well reader.
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3.3. Results

3.3.1. Sexual behavior

Sexual behavior was severely impaired in OZ rats compared to LZ controls
(Figure 3.1). Effects of strain (LZ vs. OZ) were detected for latencies to mount (F
(1,52)=5.86; p=0.019) and intromit (F (1,54)=5.55; p=0.023), numbers of mounts (F
(1,54)= 38.95; p=<0.001) and intromissions (F (1,54)=41.65; p=<0.001), copulation
efficiency (F (1,52)=159.56; p=<0.001) and inter-intromission intervals (F (1,49)=56.09;
p=<0.001). Impaired behavior was detected during all three trials, indicating that sexual
experience did not alleviate the impairments. One of the OZ males reached ejaculation
during any of the three tests compared to 100% of LZ rats.

NA ginseng improved sexual behavior in OZ males. Treatment effects were
detected on copulation efficiency (F (2,106)=8.8; p=<0.001) and numbers of intromission
(F (2,108)=4.1; p=0.020). Post hoc analyses revealed facilitative effects of aqueous
extract during test 3 and test 4, the latter with a strong trend (p = 0.062 ), and ethanol
extract during tests 1 and 4 (Figure 3.2). Hence, both extracts improved copulation
efficiency on test days. In addition, treatment effects were found on mount (F(2,
100)=12.67; p=<0.001) and intromission (F(2, 85)=13.14; p=<0.001) latencies (Table
3.1). Specifically, aqueous and ethanol extracts of NA ginseng significantly shortened
mount and intromission latencies, but only during the first test when males were sexually
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naïve. Also, aqueous extract improved intromission latency during the second test, but no
effects during the subsequent tests were found.

3.3.2, E x copula test

In addition to improving erectile function during mating behavior, NA ginseng
also improved penile reflexes determined by the ex copula tests (Figure 3.3). Ethanol,
but not aqueous, extract significantly improved total number of erections (p=0.034), and
the percentage of animals displaying E3 erections (p=0.044), with a trend towards
significance for the percentage of E3 erections (p=0.065). Other parameters were not
affected by either extract (Table 3.2).

3.3.3. eNOS and nNOS mRNA

There were no significant differences in either eNOS (OZ: 119 ± 13.5 % fold
change compared to LZ) or nNOS (OZ: 92 ± 5.7 % fold change compared to LZ) mRNA
content in penile tissue between LZ and OZ rats. Ethanol extract of NA ginseng increased
nNOS (F(2,15)=9.2; p=0.002) and eNOS (F(2,16)= 4.78; p=0.024) mRNA (Figure 3.4).
Post hoc analyses demonstrated that males chronically treated with ethanol NA ginseng
and received a final ginseng administration prior to tissue collection (EE) had increased
nNOS (p<0.001) and eNOS (p=0.008) compared to chronic saline treated groups (SS). In
contrast, chronically treated ethanol NA ginseng males that received saline on the final
day (ES) had increased nNOS (p=0.015), but not eNOS. Hence, it appears that in addition
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to the chronic treatment, the final administration prior to tissue collection affected levels
of eNOS, but not nNOS. Aqueous extract of NA ginseng did not have any effect on levels
of nNOS or eNOS (Table 3.3).

3.3.4. Body weight

NA ginseng affected weight gain in OZ males (F(2, 816)=53.935; p<0.001);
significantly lower increases in bodyweight compared to vehicle-treated males were first
detected following 25 (aqueous) or 33 days (both extracts) of daily administration (Figure
3.5) .

Testes weight and Testosterone Levels

OZ rats had a decrease in testes weight compared to LZ rats (p=0.004) (Figure
3.6) . Testes weight was increased by treatment with NA ginseng (Figure 3.6) as ethanol,
but not aqueous, extract significantly increased testes weight compared to saline-treated
controls (p=0.041). However, plasma testosterone levels were not affected by NA
ginseng as there were no significant differences between control (2.0 ± 0.2 ng/mL) and
NA ginseng-treated rats (aqueous: 1.7 ± 0.2 ng/mL, ethanol: 2.6 ± 0.4 ng/mL).

Test 2

lest 3

om

Tesi 1

Tesi 1

*
Tesi 2

j

oo
UJ
Test %

<*>

84

Figure 3.1. Latency to mount (A) and intromit (B), number of mounts (C), and
intromissions (D), copulation efficiency (mounts/intromission) (E), and inter
intromission interval (F) in adult, male Lean and Obese Zucker rats during three
consecutive tests (test 1-3). Data are presented as mean ± SEM. * indicates significance
from lean group within each test.
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30 Mins
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3
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4
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Figure 3.2. Effects of ethanol and aqueous extracts of NA ginseng on copulation
efficiency (mounts/intromission) in male Obese Zucker rats after 28 days of oral
treatment at 250 mg/kg. Behavior was examined 30 minutes (tests 1 and 3) or 24 hours
(tests 2 and 4) after last ginseng or vehicle injection. Number of animals per group:
control: n = 11, aqueous: n = 12, ethanol: n = 13. Data are presented as mean ± SEM. *
indicates significance from control within each test and # indicates p = 0.062 compared to
control.

Table 3.1. Effects of aqueous and ethanol extracts of NA ginseng on mount (ML) and
intromission (IL) latencies (seconds), frequency of mounts (# M) and intromissions (#
IM), and inter-intromission interval (I IM I; seconds) in sexually naive male Obese
Zucker rats. Behavior was examined 30 minutes (tests 1 and 3) or 24 hours (tests 2 and 4)
after last NA ginseng or vehicle injection. Number of animals per group: control: n = 11,
aqueous: n = 12, ethanol: n = 13. Data are presented as mean ± SEM. * indicates
significance from control within each test.

Control

ML
IL
#M
#IM
I IM I

Test
1
1123 ±397
1405 ±523
8± 4
3± 2
1288 ±645

Aqueous

ML
IL
#M
#IM
I IM I

202 ±115*
405± 198*
9± 3
5± 2
912 ±454

177 ±72
116 ±50*
23 ± 9
9± 3
741 ± 413

112 ± 80
171± 138
26 ± 9
9± 3
717 ± 421

26 ± 8
31 ± 6
50 ± 10
15 ± 4
396 ± 96

Ethanol

ML
IL
#M
#IM
I IM I

200 ±56*
267 ±83*
14 ± 5
9± 3
360± 129

246 ±115
349± 137
12 ± 4
3± 1
1322 ±411

113 ± 55
144 ± 82
46 ± 9
9± 2
510 ± 171

32 ± 7
110 ± 49
31 ± 8
11 ± 4
916 ±407

2
415 ±112
657 ±218
9± 4
2± 1
1813 ±734

3
85 ±27
103 ±37
34 ± 10
7±2
476 ± 95

4
34 ± 9
64 ±31
42 ± 10
6± 2
967 ±355
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Figure 3.3. Effects of ethanol and
aqueous extracts of NA ginseng on
number of erections (A), percent of E3
erections (B), and percent or rats
displaying E3 erections (C) during the
ex copula test in sexually experienced
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male Obese Zucker rats. NA ginseng or
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Table 3.2. Effects of aqueous and ethanol extracts of NA ginseng on parameters of ex
copula tests in sexually experienced, adult, male Obese Zucker rats. NA ginseng or
vehicle was administered 30 minutes prior to testing. Number of animals per group:
control: n = 8, aqueous: n = 9, ethanol: n = 12. Data are presented as mean ± SEM. No
significant differences between groups within each test were detected.

Time to First Erection
# Flips
% F2 Flips
# Clusters

Control
333.5 ±95.8
2.0 ± 1.0
7.5 ±5.0
0.5 ±0.3

Aqueous
227.2 ± 54.5
1.3 ±0.6
6.3 ± 6.3
0.3 ± 0.2

Ethanol
194.0 ±35.5
3.0 ±0.9
32.0 ± 11.6
2.0 ±0.5
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Figure 3.4. Effects of ethanol extract of NA ginseng on mRNA expression of eNOS (A)
and nNOS (B) in penile tissue. Males were treated chronically with saline or NA ginseng
(250 mg/kg) and received vehicle or ginseng (250 mg/kg) 1 hour prior to tissue
collection. Number of animals per group: saline/saline: n = 7, ethanol/saline: n = 6,
ethanol/ethanol: n = 6. Data are presented as mean ± SEM fold change compared to the
chronic saline treated control group (white bar). * indicates significant compared to
chronic saline-treated group.
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Table 3.3. Effects of aqueous extract of NA ginseng on penile eNOS and nNOS mRNA
in sexually experienced, adult, male Obese Zucker rats. NA ginseng or vehicle (250
mg/kg) was administered chronically for 50 day then rats received a final injection of
either saline or NA ginseng 1 hour prior to sacrifice. Number of animals per group:
saline/saline: n = 10, aqueous/saline: n = 5, aqueous/aqueous: n = 6. Data are presented as
mean ± SEM percent change compared to the chronic saline-treated group. No significant
differences between groups were detected.

Chronic Treatment
Final Treatment
eNOS
nNOS

Saline
Saline
107 ± 14
106 ± 13

Aqueous
Saline
76 ± 10
107 ± 4

Aqueous
Aqueous
87 ± 9
98 ± 14
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D ay

Figure 3.5. Weight of Obese Zucker rats treated with aqueous and ethanol extracts of NA
ginseng. Measurements were conducted one to two hours after lights off before daily NA
ginseng administration. Number of animals per group: control: n = 12, aqueous: n = 12,
ethanol: n = 13. Data are presented as mean ± SEM. * indicates significance from control
group within each test and # indicates significance of aqueous treatment from control.
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Figure 3.6. Percent weight of testes expressed as a percentage of body weight in Lean
and Obese Zucker control rats (A) and Obese Zucker rats (B) treated with NA ginseng or
vehicle for 50 days (250 mg/kg). Number of animals per group: Control group: n = 10,
Treatment group: control: n = 12, aqueous: n = 12, ethanol: n = 13. Data are presented as
mean ± SEM. * indicates significance from control group within each test.
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3.4. Discussion

The results of the current study show improved erectile function with chronic
administration of NA ginseng during copulation and ex copula reflex tests in OZ rats with
impaired sexual function. Specifically, ethanol and aqueous extracts of NA ginseng
treatment improved copulation efficiency, which is a measure of erectile function (Clark,
1995), without significantly altering other parameters of sexual performance. Moreover,
in ex copula reflex tests, ethanol extract increased the display of intense erections (cups),
which are associated with increased intracavemosal pressure with flaring of the tip of the
penile glans (Bemabe et al., 1995). In penile tissue, chronic treatment of ethanol, but not
aqueous, extract increased nNOS mRNA while acute treatment increased eNOS mRNA.
Finally, both extracts of NA ginseng treatment reduced weight gain after 25-33 days of
treatment, which persisted throughout the remainder of the study.

The OZ rat is a well established model of pre-diabetes, and shares similar
secondary pathologies as T2DM patients (Kasiske et al., 1992; Hidalgo-Tamola and
Chitaley, 2009). These secondary pathologies, such as obesity, insulin resistance,
decreased testosterone, and impaired vasodilation, contribute to ED (Edmonds and
Withyachumnamkul, 1980; Withyachumnamkul and Edmonds, 1982; Doherty et al.,
1985; Hemmes and Schoch, 1988). Likewise, male OZ rats display an impaired initiation
of sexual behavior (Withyachumnamkul and Edmonds, 1982), decreased intromission
frequency (Doherty et al., 1985), decreased ejaculation latency (Doherty et al., 1985), or
were unsuccessful at initiating mating (Young et al., 1986). The current results are in
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agreement with these studies. OZ rats were significantly impaired in most parameters of
sexual behavior, including initiation of mating and measures of erectile function.

PDE5 inhibitors are currently the main treatment for ED. However, diabetic men
have a diminished response to PDE5 inhibitors (Rendell et al., 1999). As such, the
decrease in efficacy of PDE5 inhibitors in the diabetic population necessitates alternate
treatments. Novel treatments have been tested to improve erectile function using rat
models with T2DM (Garcia et al., 2009; Wingard et al., 2009). In particular, Zucker
diabetic rats injected with a single dose of adipose-derived stem cells in the penis
displayed greater intracavemous pressure (ICP) upon electrostimulation than control rats
(Garcia et al., 2009). Also, Rosuvastatin, injected intraperitoneally for three days,
improved erectile response to electrostimulation compared to control (Wingard et al.,
2009). Although improved erectile function was not observed during mating, these
studies provide pharmacological treatment options for restoring erectile function in
diabetic populations. The current study demonstrated that NA ginseng can provide an
additional pharmacological option for ED treatment, as erectile function during mating as
well as in reflex tests was improved.

The current data showed differing effects of NA ginseng extracts on enhancing
erectile function in OZ rats. Although both extracts improved copulation efficiency
during mating, only ethanol extract improved ex copula reflexes. A previous study from
our laboratory also detected differing effects of the two extracts and showed that ethanol,
but not aqueous, extract improved erectile function during mating behavior in healthy,
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young, adult Long Evans rats (Barnes et al., 2011). Other research studies have reported
differing effects of ginseng on immunomodulation and cardiovascular effects based on
the solvent used to create the extract (Lee et al., 1981; Azike et al., 2011). Ginsenoside
profiles differ between extracts due to the solubilities of the ginsenosides in either ethanol
or aqueous solutions (Azike et al., 2011). The ethanol extract used in this study has a
higher percentage of ginsenoside content compared to the aqueous extract (approximately
28% to 14% dry weight, respectively) (Azike et al., 2011), including slight differences in
levels of Rbl. Ginsenoside Rbl did not prevent male mice copulatory disorder based on
measuring latencies and frequencies of sexual performance parameters (Yoshimura et a l,
1998); however, effects on erectile function have not been studied and cannot be ruled
out. Ginsenoside Rgl has been shown to improve male sexual performance (Wang et al.,
2010) but difference in concentration between extracts did not reach significance, thus, it
is unlikely to contribute to pro-erectile effects. The four remaining major ginsenosides of
the two extracts used in this study have not been tested for enhancing male sexual
function. A final contribution to the differences in effects between extracts may be due to
polysaccharides (PS). PS differ been the extracts used in this study; the aqueous extract
had detectable levels while the ethanol extract did not (Azike et al., 2011). PS in aqueous
extracts are believed to contribute to the pro-inflammatory response that increased NO
levels in macrophages while the lack of PS and increased ginsenoside concentrations in
ethanol extracts caused an anti-inflammatory response (Azike et al., 2011). As such, the
low levels of ginsenosides in the aqueous extract may be partially compensated by its
pro-inflammatory response in regards to increasing erectile function while the ethanol
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extract increases erectile function through alternate mechanisms possibly involving
central and peripheral sites of action (Barnes et al., 2011).

The mechanisms through which the ethanol extract of NA ginseng elicits its
effects on erectile function in OZ rats are unknown. A combination of factors contribute
to the development of ED in OZ rats, including obesity, impaired vasodilation, and
hyperglycemia (Gur et al., 2009; Hidalgo-Tamola and Chitaley, 2009). Villalba et al.
have shown vascular remodelling of penile arteries in OZ rats alongside increased
contractile response to high potassium-saline solutions and decreased endotheliumdependent relaxation to acetylcholine (Villalba et al., 2009). NO levels are reduced in OZ
rat arteries concomitant to reduced endothelium-dependent relaxation, which occurred
with vascular remodelling (Bouvet et al., 2007). Furthermore, decreased levels of
antioxidants and increased production of ROS, which scavenge NO in the vasculature
and decrease its bioavailability, are associated with vascular dysfunction in T2DM
(Katakam et al., 2005; Hidalgo-Tamola and Chitaley, 2009). Treatment with antioxidants
can partially rescue contractile responses in penile arteries of OZ rats (Villalba et al.,
2009). In conclusion, the above changes in the vasculature influence the NO/cGMP
pathway required for proper erectile function (Rajfer, 2008) and these physiological
changes provide mechanisms through which diabetic individuals can develop ED. In
agreement with the present results, changes in total penile eNOS have not been detected
in OZ rats compared to control (Villalba et al., 2009). Furthermore, our results do not
indicate changes in either eNOS or nNOS mRNA in penile tissue of OZ rats compared to
LZ rats. Conversely, decreased protein levels of both eNOS and nNOS in penile tissue

were detected in male rats with streptozotocin-induced T2DM (Chiou et al., 2009) or
genetic models of T2DM (Jesmin et al., 2003). It appears that changes in eNOS and
nNOS mRNA or protein levels may appear with increased severity of T2DM, as in the
current study OZ males were pre-diabetic and did not yet require insulin treatment. As
such, deregulation of eNOS and nNOS in penile tissue may not yet be established.

The current results demonstrate that ethanol, but not aqueous extract of NA
ginseng increased eNOS and nNOS mRNA expression in penile tissues of OZ males.
nNOS mRNA content was increased with chronic administration of ethanol extract while
eNOS mRNA appears to be increased acutely (one hour). Recent findings from our
laboratory show healthy, young, adult Long Evens rats administered ethanol extract of
NA ginseng had increased eNOS and nNOS mRNA in penile tissue (Bames et al., 2011).
Interestingly, both eNOS and nNOS mRNA in our previous study were increased only
with acute dosing while in this study nNOS is increased with chronic treatment and
eNOS by acute treatment. Reasons for the difference can only be speculated. Healthy
Long Evans rats may have tighter control of mRNA expression in penile tissue, thus,
nNOS mRNA content is rapidly brought to homeostatic levels, whereas in pre-diabetic
models, OZ rats may not possess such control. Furthermore, induction of mRNA, such as
nNOS, persists over a longer period. Indeed, mRNA levels of genes associated with
cardiovascular regulation have been shown to be increased or decreased in diabetic
models and may be deregulated compared to healthy controls (Banz et al., 2007; Keller
and Attie, 2010).
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The mechanism through which eNOS or nNOS mRNA is increased is unknown.
R bl, which is present in higher concentrations in the ethanol extract, and its metabolite
(compound K) have both been shown to increase eNOS phosphorylation and activity (Yu
et al., 2007; Tsutsumi et al., 2011). As such, Rbl may enhance the NO/cGMP pathway in
penile vasculature, which is required for reversal of ED in diabetes (Angulo et al., 2005).
In addition, ginsenoside Rd, among many other ginsenosides, has been shown to increase
antioxidant enzymes and decrease oxidative stress (Yokozawa et al., 2004; Ye et al.,
2011). As such, Rd may protect the vasculature from the oxidative stress that has been
linked to ED in diabetes (Hidalgo-Tamola and Chitaley, 2009). In conclusion, it is
possible that NA ginseng treatment caused enhanced vasodilation and protection from
oxidative stress, resulting in partial recovery of erectile function in OZ rats.

However, improvement of erectile function during mating behavior appeared to
occur independent of changes in eNOS or nNOS, since aqueous extract improved sexual
behavior without affecting levels of NOS. Hence, other factors must contribute to the
facilitative actions of NA ginseng on erectile function. Such factors do not appear to
involve increased production of testosterone. Circulating testosterone levels have been
shown to be decreased in OZ rats (Whitaker et a l, 1983). However, even though the
testicular weight, as a percent of total body weight, was increased with ethanol extract
treatment (indicating a potential increase in plasma testosterone levels), plasma
testosterone was not significantly affected by NA ginseng treatment. This is in agreement
with a study by Murphy and colleagues testing NA ginseng on male sexual behavior; no
effect of NA ginseng on plasma testosterone levels was measured (Murphy et al., 1998).
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Hence, it is unlikely that NA ginseng improves sexual function by increasing testosterone
production. Other factors that may have contributed to the action of NA ginseng in OZ
rats include actions on the central nervous system (Barnes et al, 2011) and future studies
are needed to test that hypothesis.

In conclusion, this study provides evidence for using the ethanol extract of NA
ginseng to partially rescue erectile function in pre-diabetes. The ethanol extract was able
to moderately enhance erectile function during mating and in an ex copula reflex test. As
such, NA ginseng may provide an additional pharmacological treatment for men with
diabetic complications that experience ED.
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Chapter 4

4.1. Discussion:

The results of these studies provide evidence of the pro-erectile effects of NA
ginseng in healthy and pre-diabetic male rats. Previous studies have shown that Asian
ginseng and ginsenoside Rgl treatment have pro-erectile properties by acting on the
NO/cGMP pathway (Chen and Lee, 1995; Wang et al., 2010); however effects of NA
ginseng on erectile function have not been investigated. One goal of this study was to
characterize two common extracts of NA ginseng. Indeed, different effects were found;
the ethanol extract enhances erectile function while the aqueous extract provided little to
no effect. An additional goal was to determine potential mechanisms through which NA
ginseng produces pro-erectile effects. We have shown a central action of NA ginseng as
indicated by an increase of nNOS in the PVN (Chapter 2) as well as a peripheral action as
indicated by increasing eNOS and nNOS mRNA in penile tissue in healthy (Chapter 2)
and pre-diabetic male rats (Chapter 3).

Chapter 2 revealed increased eNOS and nNOS mRNA one hour after injection but
no effect of chronic treatment. In contrast, increased nNOS occurred in chronically
treated pre-diabetic rats while eNOS was dependent on final injection, similar to the
healthy rats (Chapter 3). The reasons for the differences in mRNA content increases
between healthy and pre-diabetic rats can only be speculated since neither the active
constituent nor the receptor activating gene transcription is known. Transcription
deregulation has been shown in diabetic populations for genes of transcription factors

107

from overexposure to cytotoxic fatty acids (Johnstone et al., 2011) and cellular
messengers involved in gene transcription for inflammatory responses (Siqueira et al.,
2010). As such, the induction of mRNA transcription of nNOS in healthy rats may be
quickly regulated to homeostatic levels within 24 hours whereas in pre-diabetic rats, the
increase in nNOS is not as tightly regulated so chronic ethanol extract administration
increases nNOS mRNA levels, which remain high over 24 hours.

The current study has limitations when explaining the ability of NA ginseng to
enhance erectile function. Firstly, this study only measured levels of eNOS and nNOS
mRNA content in penile tissue. These levels may not translate into increased protein
content. Furthermore, the protein content may not correlate to NO activity and, as such,
further studies are needed to determine NO activity in penile and brain tissue of NA
ginseng-treated rats. In addition, a time course for NA ginseng’s effects at improving
erectile function and NO modulation are required; however, these objectives were outside
of the scope of the current study. Finally, pathways through which NA ginseng produces
effects on sexual performance need to be discovered to calculate appropriate dosing.

Although effects were detected on the NO/cGMP pathway in penile tissue and on
nNOS expression in the PVN, a disconnect exists between these effects and the
enhancement of erectile function. NA ginseng was able to increase eNOS and nNOS
mRNA content in the penis and nNOS immunoreactivity in the PVN after one hour of
dosing without any effects of chronic treatment. Conversely, NA ginseng was able to
increase CE with chronic treatment where dosing did not occur for 24 hours before
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testing. As such, although NO activity may contribute to some parameters of sexual
behavior, other mechanisms must exist.

Alternate mechanisms through which NA ginseng may be producing its effects
include activating other mediators of erection in supraspinal regions such as dopamine
and influencing spinal cord modulation. Ginseng has already been shown to modulate
dopamine release when administered with drugs of abuse (Shim et al., 2000; Kim et al.,
2006; Lee et al., 2008). Dopamine has a pro-erectile effect on brain regions including the
PVN (Baskerville et al., 2009). Furthermore, increased dopamine has been indirectly
attributed to improvements of male sexual behavior in NA ginseng-treated rats (Murphy
et al., 1998) and effects in this current study may be occur due to influences on the
dopamine system. In addition, although NA ginseng has not been shown to affect spinal
control of erections, it cannot be ruled out as a possible site of action. The spinal cord
directly controls erectile response in males (McKenna, 2000) so any influence on the
erectile pathway may enhance erectile response.

Since increased eNOS or nNOS mRNA or protein occurred with NA ginseng
injections one hour prior to measurements but did not translate to increased in copula
performance in healthy rats, it is possible that small improvements of erectile mediators
can affect ex copula reflexes but are insufficient to influence mating for which much
more erectile improvement is required. Indeed, in copula erectile function is mediated by
a complex interplay of neurochemical and hormonal inputs (Pfaus et al., 2001). Future
studies can investigate telemetry of the cavemosal bodies during copulation to determine
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if penile rigidity is increased during mating even if measures of sexual behavior do not
indicate increased erectile function. In addition, tests of telemetry of the corpus
cavemosum in anesthetised rats would help determine if acute (and chronic) NA ginseng
administration increases intracavemous pressure during electrostimulation. These
experiments would help determine the contribution of the NO/cGMP pathway in NA
ginseng’s pro-erectile effects.

Ginsenosides, regardless of their very low oral bioavailability, are detected in the
blood of canines after oral administration 10 minutes after injection (Song et a l, 2010).
In addition, although ginsenosides are not NO donors, they cause an increase in corpus
cavemosum relaxation and cGMP levels with 10 minutes of exposure (Chen and Lee,
1995; Murphy and Lee, 2002). As such, the rapid effects of ethanol extract on increased
mRNA content after administration seem to be physiologically possible within one hour
of injection.

The ginsenoside(s) responsible for the increase in erectile function and cellular
mediators of erectile function with acute NA ginseng treatment must be rapidly absorbed
and reach concentrations necessary to produce their effects. Ginsenosides are divided into
two groups based on their structures: 20(S)-protopanaxadiol (ppd) ginsenosides have
sugar moieties at either C-3, C-20, or both positions while 20(S)-protopanaxatriol (ppt)
ginsenosides have a hydroxyl group at C-3 and sugar moieties at C-6, C-20, or both
(Attele et a l, 1999). Ppd-ginsenosides include Rbl and Rd while ppt-ginsenosides
include Rgl and Re (Gillis, 1997). Notably, the ethanol extract used in this study has
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increased levels of Rbl and Rd. Intestinal absorption of ginsenosides occurs largely via
passive diffusion and, as such, ppd-ginsenosides have greater intestinal absorption and
systemic exposure due to their smaller molecular size and lipid solubility (Liu et a l,
2009). Also, ppd-ginsenosides have a much greater half-life compared to pptginsenosides (13-18 hours compared to <4 hours, respectively) and were detectible in
plasma 48 hours after oral administration (Liu et al., 2009). Even though the time to
maximal plasma concentration for ppd-ginsenosides does not occur until 6-10 hours after
oral injection, they provide the best targets for increasing erectile function after 30
minutes of dosing (with naïve pre-diabetic rats and ex copula tests) and cellular mediators
after one hour of dosing. In addition, given their long half-life they also provide the best
candidates for producing chronic effects of increased in copula erectile function in
healthy and pre-diabetic rats (after sexual experience). Furthermore, since both ppdginsenosides Rbl and Rd differ between ethanol and aqueous extracts and are part of the
six ginsenosides that constitute over 70% of the ginsenoside content of NA ginseng (Lim
et a l, 2005), they provide the best candidates for producing the pro-erectile effects seen
in the ethanol extract.

The metabolite of ginsenoside Rbl, Compound K, which is the main form
absorbed after intestinal bacteria metabolism, has been shown to phosphorylate and
active eNOS in vivo (Tsutsumi et a l, 2011). In penile tissue, increased eNOS activity
would lead to increased production of cGMP through increased NO levels, which would
contribute to erection induction. In addition, ginsenoside Rbl has anti-diabetic and
insulin-sensitizing effects; Rbl stimulated glucose transport by promoting the
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translocation of GLUT1 and GLUT 4 (Shang et al., 2007; Shang et al., 2008).
Furthermore, given the long half-life of Rbl, any improvement in diabetic symptoms
could cause long-term improvements that reduce the intensity of secondary pathologies
of diabetes and, alongside increased in eNOS phosphorylation, it may contribute to proerectile effects. In addition, ginsenoside Rd which is also a ppd-ginsenoside, increases
endogenous oxidative defences in senescence mice by improving the
glutathione/glutathione disulphide ratio and decreasing markers of lipid peroxidation
(Yokozawa et al., 2004). As such, with increased endogenous scavenging for ROS, more
NO is free to act on penile smooth muscle cells to induce penile erections with
ginsenoside Rd treatment (Hidalgo-Tamola and Chitaley, 2009).

In regards to ppt-ginsenosides, ginsenoside Rgl may be able to further increase
NO production which it has been shown in bovine aortic endothelial cells (Kim et al.,
1992) and in penile tissue alongside increased measures of sexual performance (Wang et
al., 2010). The increase in NO production would not be scavenged by ROS due to the
antioxidant effects of ginsenosides Rd and Rbl. One final consideration for the
differences between extracts, the ethanol extract may provide the minimum effective dose
(MED) required for pro-erectile effects given that its ginsenoside concentration is greater
(28%) than the aqueous extract (14%). If multiple ginsenosides are able to meet the MED
required then synergistic, pro-erectile effects of NA ginseng can contribute to the
improvements of erectile function in copula and during reflex tests seen in this study.
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Ginseng extracts have been shown to improve self-reported measures of erectile
function in humans and improve erection rigidity while men were exposed to audio and
visual stimulation (Hong et al., 2002; Jang et al., 2008). However, NA ginseng has not
been tested in human populations. The results of this study indicate a potential for ethanol
extract of NA ginseng to improve erectile function in healthy and diabetic human
populations with ED. Given that a greater proportion of diabetic men do not report
positive responses to PDE5 inhibitors (Rendell et al., 1999), NA ginseng may provide
another pharmacological treatment option and is well tolerated with reports of a few mild
side effects (Gillis, 1997). A combination therapy of NA ginseng with PDE5 inhibitors
may provide addition benefits over PDE5 inhibitors alone. In summary, NA ginseng can
increase endogenous production of NO and therefore cGMP content while PDE5
inhibitors prevent the degradation of cGMP. As such, cGMP can activate the cellular
mediators needed to initiate an erection.

In conclusion, the results of this study demonstrated the effects of two NA
ginseng extracts on erectile function and sexual behavior in healthy and pre-diabetic rats
with ED. Moreover, ethanol extract of NA ginseng was successful at increasing erectile
function in copula in healthy rats with both central (PVN) and peripheral (penile tissue)
sites of action. In pre-diabetic rats, ethanol extract increased erectile function in copula as
well as penile reflexes with a peripheral site of action (penile tissue), although central
sites of actions were not investigated. In summary, ethanol extract of NA ginseng can be
used for enhancing erectile function in healthy or pre-diabetic male rats and future tests
may show a translation to increased erectile function in humans.
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